PL1641913T3 - Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania - Google Patents

Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania

Info

Publication number: PL1641913T3
Authority: PL; Poland
Prior art keywords: making; methods; same; umbilical cord; cells derived
Prior art date: 2003-06-27

Application number

PL04756395T

Other languages

English (en)

Inventor

Sanjay Mistry

Anthony J Kihm

Ian Ross Harris

Alexander M Harmon

Darin J Messina

Agnieszka Seyda

Chin-Feng Yi

Anna Gosiewska

Original Assignee

Depuy Synthes Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2004-06-25

Publication date

2016-06-30

2004-06-25 Application filed by Depuy Synthes Products Inc filed Critical Depuy Synthes Products Inc

2016-06-30 Publication of PL1641913T3 publication Critical patent/PL1641913T3/pl

Links

210000003954 umbilical cord Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Cell Biology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)

PL04756395T 2003-06-27 2004-06-25 Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania PL1641913T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US48326403P	2003-06-27	2003-06-27
EP04756395.2A EP1641913B1 (en)	2003-06-27	2004-06-25	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
PCT/US2004/020931 WO2005003334A2 (en)	2003-06-27	2004-06-25	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

Publications (1)

Publication Number	Publication Date
PL1641913T3 true PL1641913T3 (pl)	2016-06-30

Family

ID=38456561

Family Applications (14)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych
PL04756395T PL1641913T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich

Family Applications Before (11)

Application Number	Title	Priority Date	Filing Date
PL04777287T PL1641918T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
PL04777234T PL1641915T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek otrzymanych poporodowo
PL04809466T PL1649013T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa chrząstki i kości z wykorzystaniem komórek poporodowych
PL04777235T PL1641916T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
PL04777286.8T PL1641917T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek miękkich przy zastosowaniu komórek pozyskiwanych poporodowo
PL10184796T PL2336298T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL04777231T PL1641914T3 (pl)	2003-06-27	2004-06-25	Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
PL10184221T PL2338981T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanek oka z wykorzystaniem komórek pochodzących z pępowiny poporodowej
PL10184306T PL2338982T3 (pl)	2003-06-27	2004-06-25	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL10183911T PL2341131T3 (pl)	2003-06-27	2004-06-25	Naprawa i regeneracja tkanki chrzęstnej i kostnej z wykorzystaniem komórek uzyskanych po porodzie
PL10184137T PL2338980T3 (pl)	2003-06-27	2004-06-25	Regeneracja i naprawa tkanki nerwowej z wykorzystaniem poporodowych komórek pępowinowych

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PL10183053T PL2399990T3 (pl)	2003-06-27	2004-06-25	Komórki otrzymane z poporodowej pępowiny do zastosowania w leczeniu chorób serca i układu krążenia
PL10184593T PL2322599T3 (pl)	2003-06-27	2004-06-25	Komórki pozyskiwane poporodowo z tkanki sznura pępowinowego i sposoby pozyskiwania i zastosowania tych komórek do naprawy i regeneracji tkanek miękkich

Country Status (8)

Country	Link
US (28)	US7560276B2 (pl)
EP (14)	EP2399990B1 (pl)
JP (7)	JP4948166B2 (pl)
AU (7)	AU2004252566B2 (pl)
CA (7)	CA2530732C (pl)
ES (14)	ES2600555T3 (pl)
PL (14)	PL1641918T3 (pl)
WO (7)	WO2005001077A2 (pl)

Families Citing this family (577)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8563232B2 (en)	2000-09-12	2013-10-22	Lifenet Health	Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20080077251A1 (en) *	1999-06-07	2008-03-27	Chen Silvia S	Cleaning and devitalization of cartilage
US20020095157A1 (en) *	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2305795B1 (en) *	2000-12-06	2019-07-03	Celularity, Inc.	Method of collecting placental stem cells
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
EP2316918B1 (en) *	2001-02-14	2015-07-01	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
ES2432493T3 (es) *	2001-02-14	2013-12-03	Anthrogenesis Corporation	Placenta de mamífero post-parto, su uso y células madre de la misma
IL159895A0 (en) *	2001-07-20	2004-06-20	Technion Res & Dev Foundation	Methods of generating human cardiac cells and tissues and uses thereof
US7677565B2 (en)	2001-09-28	2010-03-16	Shuffle Master, Inc	Card shuffler with card rank and value reading capability
US20080299090A1 (en) *	2002-02-25	2008-12-04	Kansas State University Research Foundation	Use Of Umbilical Cord Matrix Cells
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20080003258A1 (en) *	2002-10-16	2008-01-03	Marcum Frank D	Composition and Method for Treating Rheumatoid Arthritis
US7824701B2 (en)	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en) *	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
AU2003298775B2 (en)	2002-11-26	2008-07-17	Anthrogenesis Corporation	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
WO2004069172A2 (en)	2003-01-30	2004-08-19	The Government of the United States of America as represented by the Department of Veterans Affairs	Multilineage-inducible cells and uses thereof
EP2277992A3 (en)	2003-02-11	2011-03-02	John E. Davies	Progenitor cells from Wharton's jelly of human umbilical cord
CN1770976A (zh) *	2003-02-13	2006-05-10	人类起源公司	利用脐带血治疗患有疾病、紊乱或状况的个体的用途
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
ATE470199T1 (de) *	2003-04-24	2010-06-15	Koninkl Philips Electronics Nv	Eingriffsfreie links-herzkammervolumenbestimmung
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
EP2399990B1 (en)	2003-06-27	2015-07-22	DePuy Synthes Products, Inc.	Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8491883B2 (en) *	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US8226715B2 (en)	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en)	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
CA2533124C (en) *	2003-08-12	2014-01-28	Tigenix N.V.	Use of cxcl6 chemokine in the prevention or repair of cartilage defects
US8043614B2 (en)	2004-03-09	2011-10-25	Ahlfors Jan-Eric W	Autogenic living scaffolds and living tissue matrices: methods and uses thereof
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
US7316822B2 (en)	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
US7682828B2 (en)	2003-11-26	2010-03-23	Whitehead Institute For Biomedical Research	Methods for reprogramming somatic cells
KR20120039065A (ko) *	2003-12-02	2012-04-24	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
US7901461B2 (en) *	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
JP2005168360A (ja) *	2003-12-09	2005-06-30	Olympus Corp	生体組織補填体の検査方法、装置、細胞培養容器および培養状態検査方法
US20050176139A1 (en) *	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
WO2005071066A1 (en) *	2004-01-23	2005-08-04	Board Of Regents, The University Of Texas System	Methods and compositions for preparing pancreatic insulin secreting cells
US11395865B2 (en)	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
EP2298864B1 (en)	2004-03-22	2017-10-11	Mesoblast International Sàrl	Mesenchymal stem cells and uses therefor
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8137686B2 (en)	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
WO2005108559A2 (en) *	2004-04-23	2005-11-17	Bioe, Inc.	Multi-lineage progenitor cells
US7622108B2 (en)	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
WO2005107807A2 (en) *	2004-05-06	2005-11-17	University Of South Florida	Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis
US8802651B2 (en) *	2004-06-30	2014-08-12	Abbott Medical Optics Inc.	Hyaluronic acid in the enhancement of lens regeneration
US7794697B2 (en)	2004-06-30	2010-09-14	Abbott Medical Optics Inc.	Enhancement of lens regeneration using materials comprising polysiloxane polymers
US20060083732A1 (en) *	2004-06-30	2006-04-20	Arlene Gwon	Hyaluronic acid in the enhancement of lens regeneration
KR101322889B1 (ko)	2004-08-16	2013-10-30	셀리서치 코포레이션 피티이 리미티드	제대의 양막으로부터 줄기/전구세포의 추출
US20060045872A1 (en) *	2004-08-25	2006-03-02	Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco	Use of adipose tissue-derived stromal stem cells in treating fistula
US20060069008A1 (en) *	2004-09-28	2006-03-30	Sanjay Mistry	Treatment of neurological deficits in the striatum or substanta nigra pars compacta
US8039258B2 (en) *	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20080038316A1 (en) *	2004-10-01	2008-02-14	Wong Vernon G	Conveniently implantable sustained release drug compositions
US8114841B2 (en) *	2004-10-14	2012-02-14	Biomimetic Therapeutics, Inc.	Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
US7473678B2 (en) *	2004-10-14	2009-01-06	Biomimetic Therapeutics, Inc.	Platelet-derived growth factor compositions and methods of use thereof
US7842304B2 (en) *	2004-10-29	2010-11-30	Nexeon Medsystems, Inc.	Methods and apparatus for treating an injured nerve pathway
US11660317B2 (en)	2004-11-08	2023-05-30	The Johns Hopkins University	Compositions comprising cardiosphere-derived cells for use in cell therapy
US8017395B2 (en) *	2004-12-17	2011-09-13	Lifescan, Inc.	Seeding cells on porous supports
US20060171930A1 (en) *	2004-12-21	2006-08-03	Agnieszka Seyda	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060153815A1 (en) *	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
US20060166361A1 (en) *	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
EP1838842A2 (en) *	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
CA2589041C (en) *	2004-12-23	2019-08-20	DePuy Synthes Products, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
EP1831355A2 (en) *	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
EP1835924B1 (en)	2004-12-23	2013-08-21	Ethicon, Incorporated	Treatment of parkinson's disease and related disorders using postpartum derived cells
WO2006088867A2 (en) *	2005-02-15	2006-08-24	Medistem Laboratories, Incorporated	Method for expansion of stem cells
WO2006093276A1 (ja) *	2005-03-04	2006-09-08	Kyoto University	心臓組織由来の多能性幹細胞
US20060222634A1 (en)	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
CN103361301A (zh) *	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	高度纯化来自羊膜的细胞群
US8153430B2 (en) *	2005-03-31	2012-04-10	Stemnion, Inc.	Methods related to surgery
US8999706B2 (en) *	2005-04-12	2015-04-07	The Trustees Of The University Of Pennsylvania	Methods for preparation of human hair-follicle derived multipotent adult stem cells
WO2006113731A2 (en) *	2005-04-20	2006-10-26	University Of Florida Research Foundation, Inc.	Bone marrow-derived neurogenic cells and uses thereof
US20100087546A1 (en) *	2005-04-20	2010-04-08	Biogenic Innovations, Llc	Use of dimethyl sulfone (msm) to reduce homocysteine levels
EP1879606B1 (en) *	2005-04-25	2013-06-12	Massachusetts Institute of Technology	Self-assembling peptides for promoting hemostasis
AU2006202209B2 (en) *	2005-05-27	2011-04-14	Lifescan, Inc.	Amniotic fluid derived cells
CA2613889A1 (en) *	2005-06-08	2006-12-14	Centocor, Inc.	A cellular therapy for ocular degeneration
GB0511723D0 (en) *	2005-06-09	2005-07-13	Smith & Nephew	Placental stem cells
WO2006135899A2 (en) *	2005-06-13	2006-12-21	The Johns Hopkins University	Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord
RU2284190C1 (ru) *	2005-06-14	2006-09-27	Дмитрий Дмитриевич Генкин	Способ лечения ишемической болезни сердца, или инфаркта миокарда и его последствий, или ишемии мозга, вызванной атеросклерозом или острым нарушением мозгового кровообращения, и ее последствий, или ишемии нижних конечностей, вызванной атеросклерозом
US7838503B2 (en) *	2005-06-15	2010-11-23	Children's Medical Center Corporation	Methods for extending the replicative lifespan of cells
US20150119794A1 (en) *	2005-08-05	2015-04-30	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
US20140336514A1 (en) *	2005-08-05	2014-11-13	Gholam A. Peyman	Methods to regulate polarization and enhance function of cells
EP1966229B1 (en)	2005-09-12	2015-10-21	Abela Pharmaceuticals, Inc.	Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
EP1937286B1 (en)	2005-09-12	2016-03-09	Abela Pharmaceuticals, Inc.	Compositions comprising dimethyl sulfoxide (dmso)
US8480797B2 (en)	2005-09-12	2013-07-09	Abela Pharmaceuticals, Inc.	Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033180A1 (en)	2005-09-12	2007-03-22	Abela Pharmaceuticals, Inc.	Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
JP2007106760A (ja) *	2005-09-16	2007-04-26	Kenji Yoshida	造血幹細胞増殖剤
EP3184630B1 (en)	2005-09-23	2019-07-17	TiGenix, S.A.U.	Cell populations having immunoregulatory activity, method for isolation and uses
US8182840B2 (en)	2005-09-27	2012-05-22	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
ZA200803929B (en) *	2005-10-13	2009-08-26	Anthrogenesis Corp	Production of oligodendrocytes from placenta-derived stem cells
NZ597304A (en) *	2005-10-13	2013-06-28	Anthrogenesis Corp	Immunomodulation using placental stem cells
JP4921767B2 (ja) *	2005-10-14	2012-04-25	株式会社カネカ	細胞の分化誘導方法
US10117900B2 (en) *	2005-11-09	2018-11-06	Athersys, Inc.	MAPC treatment of brain injuries and diseases
US11000546B2 (en)	2005-11-09	2021-05-11	Athersys, Inc.	Immunomodulatory properties of MAPCs and uses thereof
US20070178067A1 (en) *	2005-11-09	2007-08-02	John Maier	System and method for cytological analysis by raman spectroscopic imaging
US20090170059A1 (en) *	2005-11-14	2009-07-02	Hans Klingemann	Methods for Preparing Cord Matrix Stem Cells (CMSC) for Long Term Storage and for Preparing a Segment of umbilical cord for cryopreservation
WO2007070870A1 (en) *	2005-12-16	2007-06-21	Ethicon, Inc.	Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US8741638B2 (en) *	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
CN103173401A (zh)	2005-12-22	2013-06-26	简·恩尼斯	来自冷冻的脐带组织的活细胞
CN105106239A (zh) *	2005-12-28	2015-12-02	伊西康公司	使用产后衍生细胞治疗外周血管疾病
EP1979050B1 (en) *	2005-12-28	2017-04-19	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using postpartum-derived cells
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
ZA200804717B (en) *	2005-12-29	2010-02-24	Anthrogenesis Corp	Improved composition for collecting and preserving a placental stem cells and methods of using the composition
EP1976978A2 (en)	2005-12-29	2008-10-08	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
PL2471907T3 (pl)	2005-12-29	2019-07-31	Celularity, Inc.	Populacje komórek macierzystych łożyska
EP1981970A4 (en)	2006-01-11	2009-10-21	Technion Res & Dev Foundation	TISSUE CONSTRUCTION TISSUE TREATMENT DERIVED FROM A HUMAN EMBRYONIC STEM CELL
US20070253931A1 (en) *	2006-01-12	2007-11-01	Osiris Therapeutics, Inc.	Use of mesenchymal stem cells for treating genetic diseases and disorders
US20080286249A1 (en) *	2006-01-12	2008-11-20	Varney Timothy R	Use of mesenchymal stem cells for treating genetic diseases and disorders
GB0600972D0 (en) *	2006-01-18	2006-03-01	Univ Leeds	Enrichment of cells
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
US7875451B2 (en) *	2006-01-19	2011-01-25	The University Of Washington	Formulation to improve survival of transplanted cells
US11992507B2 (en)	2006-01-23	2024-05-28	Abt Holding Company	MAPC therapeutics without adjunctive immunosuppressive treatment
CA2640185A1 (en) *	2006-01-24	2007-08-02	Christopher J. Centeno	Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
FR2896511B1 (fr) *	2006-01-26	2012-10-26	Centre Nat Rech Scient	Procede de culture de cellules issues du tissu adipeux et leurs applications.
ES2427993T3 (es)	2006-02-09	2013-11-05	Biomimetic Therapeutics, Llc	Composiciones y métodos para el tratamiento de hueso
CA2644508A1 (en) *	2006-03-01	2007-09-07	The Regenerative Medicine Institute	Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
WO2007099337A1 (en) *	2006-03-01	2007-09-07	Cartela R&D Ab	Expansion and differentiation of mesenchymal stem cells
EP2548951B1 (en) *	2006-03-23	2016-05-04	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US20110171182A1 (en) *	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
CA2646491A1 (en) *	2006-04-17	2007-10-25	Bioe, Inc.	Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
WO2007124023A2 (en) *	2006-04-21	2007-11-01	Wake Forest University Health Sciences	Ink-jet printing of tissues
US9456979B2 (en) *	2006-04-27	2016-10-04	Sri International	Adminstration of intact mammalian cells to the brain by the intranasal route
US8741643B2 (en)	2006-04-28	2014-06-03	Lifescan, Inc.	Differentiation of pluripotent stem cells to definitive endoderm lineage
CA2649874C (en)	2006-05-05	2015-01-27	John E. Davies	Immune privileged and modulatory progenitor cells
EP4094578A1 (en) *	2006-05-11	2022-11-30	Celularity Inc.	Methods for collecting and using placenta cord blood stem cells
WO2007146106A2 (en) *	2006-06-05	2007-12-21	Cryo- Cell International, Inc.	Procurement, isolation and cryopreservation of maternal placental cells
US20080050814A1 (en) *	2006-06-05	2008-02-28	Cryo-Cell International, Inc.	Procurement, isolation and cryopreservation of fetal placental cells
KR20090031895A (ko) *	2006-06-09	2009-03-30	안트로제네시스 코포레이션	태반 니치 및 줄기 세포 배양을 위한 이의 용도
EP2035093A4 (en) *	2006-06-14	2010-02-17	Stemnion Inc	METHODS FOR TREATING SPINAL CORD INJURY AND MINIMIZING THE SCALING SCALE
US8475788B2 (en) *	2006-06-14	2013-07-02	Stemnion, Inc.	Methods of treating spinal cord injury and minimizing scarring
US20070292401A1 (en) *	2006-06-20	2007-12-20	Harmon Alexander M	Soft tissue repair and regeneration using stem cell products
TW200810769A (en) *	2006-06-28	2008-03-01	Univ Kansas	Differentiation of stem cells from umbilical cord matrix into hepatocyte lineage cells
CA2656278C (en)	2006-06-30	2016-02-09	Biomimetic Therapeutics, Inc.	Compositions and methods for treating rotator cuff injuries
US9161967B2 (en)	2006-06-30	2015-10-20	Biomimetic Therapeutics, Llc	Compositions and methods for treating the vertebral column
US20080124276A1 (en)	2006-07-24	2008-05-29	Lifeline Cell Technology	Synthetic cornea from retinal stem cells
US7993918B2 (en) *	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US8822030B2 (en)	2006-08-11	2014-09-02	Aqua Resources Corporation	Nanoplatelet metal hydroxides and methods of preparing same
US20080171158A1 (en) *	2006-08-11	2008-07-17	Aqua Resources Corporation	Nanoplatelet copper hydroxides and methods of preparing same
US7671014B2 (en) *	2006-08-14	2010-03-02	Warsaw Orthopedic, Inc.	Flowable carrier matrix and methods for delivering to a patient
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
JP5656183B2 (ja) *	2006-08-22	2015-01-21	国立大学法人東京医科歯科大学	滑膜由来間葉幹細胞（ＭＳＣｓ）の軟骨・半月板再生への応用
US20080082170A1 (en) *	2006-09-29	2008-04-03	Peterman Marc M	Apparatus and methods for surgical repair
US20080078412A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant
US20080078411A1 (en) *	2006-10-03	2008-04-03	Restore Medical, Inc.	Tongue implant for sleep apnea
CN101595212B (zh)	2006-10-12	2014-04-30	伊西康公司	肾源细胞及在组织修复和再生中的使用方法
EP1913869A3 (en) *	2006-10-19	2008-12-10	Esaote S.p.A.	Diagnostic imaging method and apparatus for the anatomical region of the pelvic floor
US8562972B2 (en)	2006-10-23	2013-10-22	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
US8106008B2 (en) *	2006-11-03	2012-01-31	Biomimetic Therapeutics, Inc.	Compositions and methods for arthrodetic procedures
CN101611139B (zh) *	2006-11-13	2012-07-04	伊西康公司	利用微载体的产后来源的细胞的体外扩增
US20080132803A1 (en) *	2006-11-30	2008-06-05	Hyman Friedlander	Method and system for doing business by mining the placental-chord complex
WO2008073331A2 (en) *	2006-12-07	2008-06-19	Teva Pharmaceutical Industries Ltd.	Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
WO2008082525A1 (en) *	2006-12-19	2008-07-10	National Stem Cell Inc	Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
WO2008083223A1 (en) *	2006-12-28	2008-07-10	Isolagen Technologies, Inc.	Methods for culturing dermal cells for treatment of skin injuries such as burns
US7980000B2 (en) *	2006-12-29	2011-07-19	Applied Materials, Inc.	Vapor dryer having hydrophilic end effector
US8221741B2 (en)	2007-01-17	2012-07-17	Marshall Vivienne S	Methods for modulating inflammatory and/or immune responses
CA2677679A1 (en)	2007-02-12	2008-08-21	Anthrogenesis Corporation	Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
NZ612888A (en)	2007-02-12	2015-02-27	Anthrogenesis Corp	Treatment of inflammatory diseases using placental stem cells
EP2125000A2 (en) *	2007-02-20	2009-12-02	Biomimetic Therapeutics, Inc.	Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix
BRPI0807966A2 (pt) *	2007-03-01	2014-06-10	Cryo Cell Int	Aquisição, isolação e criopreservação de células endometriais/menstruais
WO2008109816A1 (en) *	2007-03-08	2008-09-12	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
EP2626416A3 (en) *	2007-04-07	2013-12-18	The Whitehead Institute for Biomedical Research	Reprogramming of somatic cells
WO2009008928A2 (en)	2007-04-13	2009-01-15	Stemnion, Inc.	Methods for treating nervous system injury and disease
EP2137300B1 (en)	2007-04-26	2011-10-26	Ramot at Tel-Aviv University Ltd.	Pluripotent autologous stem cells from oral or gastrointestinal mucosa
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US20100291042A1 (en)	2007-05-03	2010-11-18	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8114668B2 (en) *	2007-05-14	2012-02-14	Cardiac Pacemakers, Inc.	Composition for cold storage of stem cells
EP2146728A4 (en)	2007-05-21	2010-12-29	Univ Wake Forest Health Sciences	PROGENITOR CELLS FROM URINE AND METHODS FOR THEIR USE
US20100111914A1 (en)	2007-05-21	2010-05-06	Yuanyuan Zhang	Stem cells from urine and methods for using the same
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US20090053182A1 (en) *	2007-05-25	2009-02-26	Medistem Laboratories, Inc.	Endometrial stem cells and methods of making and using same
DE602007010434D1 (de) *	2007-06-01	2010-12-23	Allergan Inc	Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe
US9693486B1 (en) *	2007-06-14	2017-06-27	Switch, Ltd.	Air handling unit with a canopy thereover for use with a data center and method of using the same
CA2688504A1 (en)	2007-06-18	2008-12-24	Children's Hospital & Research Center At Oakland	Method of isolating stem and progenitor cells from placenta
US20090004271A1 (en)	2007-06-29	2009-01-01	Brown Laura J	Morselized foam for wound treatment
US20090004253A1 (en) *	2007-06-29	2009-01-01	Brown Laura J	Composite device for the repair or regeneration of tissue
US9080145B2 (en)	2007-07-01	2015-07-14	Lifescan Corporation	Single pluripotent stem cell culture
US9095562B2 (en)	2007-07-05	2015-08-04	Regenerative Sciences, Inc.	Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
DE102007034679A1 (de)	2007-07-25	2009-01-29	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Materialzusammensetzungen, welche aus exokrinem Drüsengewebe erhaltene adulte Stammzellen enthalten, insbesondere zur Verwendung in der Regenerationsmedizin, z.B. zur Wiederherstellung von verletztem oder geschädigtem Myokardgewebe
US20090024224A1 (en)	2007-07-16	2009-01-22	Chen Silvia S	Implantation of cartilage
EP2192908A4 (en) *	2007-07-25	2010-09-01	Bioe Inc	DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES
US8198245B2 (en)	2007-07-27	2012-06-12	Humacyte, Inc.	Compositions and methods for soft tissue augmentation
CA3114827C (en)	2007-07-31	2023-09-05	Lifescan, Inc.	Differentiation of human embryonic stem cells to pancreatic endocrine
CA2695863A1 (en) *	2007-08-08	2009-02-12	Pervasis Therapeutics, Inc.	Materials and methods for treating skeletal system damage and promoting skeletal system repair and regeneration
US20090062907A1 (en) *	2007-08-31	2009-03-05	Quijano Rodolfo C	Self-expanding valve for the venous system
US20090068153A1 (en) *	2007-09-06	2009-03-12	Vitelli Francesca P	Cell composition for tissue regeneration
EP4559488A3 (en)	2007-09-07	2025-08-13	MiMedx Group, Inc.	Placental tissue grafts and improved methods of preparing and using the same
KR20140107677A (ko) *	2007-09-19	2014-09-04	플루리스템 리미티드	지방 또는 태반 조직 유래의 부착 세포 및 이의 치료 용도
WO2009042768A1 (en) *	2007-09-25	2009-04-02	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Triggerably dissolvable hollow fibers for controlled delivery
KR20220122774A (ko) *	2007-09-26	2022-09-02	셀룰래리티 인코포레이티드	인간 태반 관류액으로부터의 혈관형성 세포
RU2536242C2 (ru)	2007-09-28	2014-12-20	Антродженезис Корпорейшн	Угнетение опухолей с помощью плацентарного перфузата человека и выделенных из плаценты человека вспомогательных натуральных клеток-киллеров
ES2525718T3 (es) *	2007-10-05	2014-12-29	DePuy Synthes Products, LLC	Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano
WO2009052209A2 (en) *	2007-10-16	2009-04-23	University Of Kansas	Isolation of stem cells and effective control of contamination
WO2009052459A1 (en) *	2007-10-19	2009-04-23	University Of Medicine And Dentistry Of New Jersey	A method of using an extracellular matrix to enhance cell transplant survival and differentiation
US20120219737A1 (en)	2007-10-19	2012-08-30	University Of Medicine And Dentistry Of New Jersey	Production of extracellular matrix, conditioned media and uses thereof
EP2217329B1 (en) *	2007-11-07	2018-01-10	Anthrogenesis Corporation	Use of umbilical cord blood in the treatment of premature birth complications
US20110086080A1 (en) *	2007-11-14	2011-04-14	Osteosphere, Llc	Ex-vivo production of human demineralized bone matrix
EP2229434B1 (en)	2007-11-27	2011-09-07	Lifescan, Inc.	Differentiation of human embryonic stem cells
CN101945994A (zh) *	2007-12-19	2011-01-12	再生科学有限责任公司	促进干细胞移植和植入的组合物和方法
US20090163990A1 (en) *	2007-12-19	2009-06-25	Chunlin Yang	Decellularized omentum matrix and uses thereof
US8236538B2 (en) *	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
US20120156134A1 (en)	2007-12-20	2012-06-21	Shayne Squires	Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
UA99167C2 (ru) *	2007-12-27	2012-07-25	Этикон, Инкорпорейтед	Лечение дегенерации межреберных дисков с использованием клеток, полученных из ткани пуповины человека
US20100279413A1 (en) *	2008-01-14	2010-11-04	Zymes, Llc	Applications of ubiquinones and ubiquinols
US8088163B1 (en)	2008-02-06	2012-01-03	Kleiner Jeffrey B	Tools and methods for spinal fusion
EP2259807B1 (en)	2008-02-07	2013-04-24	Biomimetic Therapeutics, Inc.	Compositions for distraction osteogenesis
WO2009098698A2 (en) *	2008-02-07	2009-08-13	Shahar Cohen	Compartmental extract compositions for tissue engineering
US20090209456A1 (en) *	2008-02-19	2009-08-20	Iliana Sweis	Compositions and methods for improving facial and body aesthetics
KR101731474B1 (ko)	2008-02-21	2017-05-11	얀센 바이오테크 인코포레이티드	세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
US8318485B2 (en) *	2008-02-25	2012-11-27	Natalie Gavrilova	Stem cell therapy for the treatment of diabetic retinopathy and diabetic optic neuropathy
US20090220995A1 (en) *	2008-02-28	2009-09-03	Sachs David H	Multiple administrations of umbilicus derived cells
US20090232782A1 (en) *	2008-03-14	2009-09-17	Yu-Show Fu	Method for treating brain ischemic injury through transplantation of human umbilical mesenchymal stem cells
US20110052533A1 (en) *	2008-03-14	2011-03-03	Regenerative Sciences, Llc	Compositions and Methods for Cartilage Repair
CA2721870C (en)	2008-04-21	2020-12-22	Tissue Regeneration Therapeutics, Inc.	Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8623648B2 (en)	2008-04-24	2014-01-07	Janssen Biotech, Inc.	Treatment of pluripotent cells
US9358320B2 (en)	2008-04-25	2016-06-07	Allosource	Multi-layer tissue patches
US9480549B2 (en)	2008-04-25	2016-11-01	Allosource	Multi-layer tissue patches
JP2011519616A (ja)	2008-04-30	2011-07-14	エシコン・インコーポレイテッド	組織工学による血管
US20110143429A1 (en) *	2008-04-30	2011-06-16	Iksoo Chun	Tissue engineered blood vessels
CA2724839A1 (en) *	2008-05-21	2009-11-26	Bioe Llc	Differentiation of multi-lineage progenitor cells to pancreatic cells
US20210378834A1 (en)	2008-05-22	2021-12-09	Spinal Surgical Strategies, Inc., A Nevada Corporation D/B/A Kleiner Device Labs	Spinal fusion cage system with inserter
WO2010011407A2 (en) *	2008-05-23	2010-01-28	President And Fellows Of Harvard College	Methods of generating patterned soft substrates and uses thereof
US20090297485A1 (en) *	2008-05-28	2009-12-03	Allan Mishra	Compositions and methods for treating psychiatric and neurodegenerative disorders
CA2727625A1 (en) *	2008-06-11	2009-12-17	The Children's Mercy Hospital	Composition comprising decellularized tissue
EP3231869A1 (en)	2008-06-13	2017-10-18	Whitehead Institute for Biomedical Research	Programming and reprogramming of cells
WO2009158480A2 (en) *	2008-06-26	2009-12-30	Kci Licensing, Inc.	Stimulation of cartilage formation using reduced pressure treatment
JP5294041B2 (ja) *	2008-06-27	2013-09-18	独立行政法人産業技術総合研究所	膵臓疾患又は糖尿病のための膵臓細胞再生移植用キット
PL2310492T3 (pl)	2008-06-30	2015-12-31	Janssen Biotech Inc	Różnocowanie pluripotencjalnych komórek macierzystych
EP2318516A1 (en) *	2008-06-30	2011-05-11	Centocor Ortho Biotech Inc.	Differentiation of pluripotent stem cells
US20100028307A1 (en) *	2008-07-31	2010-02-04	O'neil John J	Pluripotent stem cell differentiation
KR20200011604A (ko)	2008-08-20	2020-02-03	안트로제네시스 코포레이션	개선된 세포 조성물 및 그의 제조 방법
CA2734237C (en) *	2008-08-20	2019-07-02	Anthrogenesis Corporation	Treatment of stroke using isolated placental cells
CA2734446C (en) *	2008-08-22	2017-06-20	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
RU2539786C2 (ru)	2008-09-02	2015-01-27	Плуристем Лтд.	Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
KR20110067035A (ko)	2008-09-09	2011-06-20	바이오미메틱 세라퓨틱스, 인크.	건 및 인대 손상의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
US9446227B2 (en)	2008-09-12	2016-09-20	Sonescence, Inc.	Ultrasonic dispersion of compositions in tissue
US20100069827A1 (en) *	2008-09-12	2010-03-18	Barry Neil Silberg	Pre-Surgical Prophylactic Administration of Antibiotics and Therapeutic Agents
KR101670099B1 (ko)	2008-10-06	2016-10-27	가부시끼가이샤 쓰리디 매트릭스	조직 폐색제
US20110300203A1 (en) *	2008-10-22	2011-12-08	Trustees Of Columbia University In The City Of New York	Cartilage regeneration without cell transplantation
PL2346988T3 (pl) *	2008-10-31	2017-10-31	Janssen Biotech Inc	Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki
CN104357381A (zh) *	2008-10-31	2015-02-18	辛西斯有限责任公司	用于活化干细胞的方法和装置
MX349178B (es)	2008-10-31	2017-07-17	Centocor Ortho Biotech Inc	Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
BRPI0921494A2 (pt)	2008-11-03	2018-10-30	Prad Reasearch And Development Ltd	método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
RU2015130665A (ru) *	2008-11-19	2018-12-24	Антродженезис Корпорейшн	Амниотические адгезивные клетки
ES2642070T3 (es)	2008-11-20	2017-11-15	Janssen Biotech, Inc.	Cultivo de células madre pluripotentes en microportadores
ES2584053T3 (es)	2008-11-20	2016-09-23	Janssen Biotech, Inc.	Métodos y composiciones para la unión de células y cultivo en sustratos planos
CA2740803A1 (en) *	2008-11-20	2010-05-27	Lifecell Corporation	Method for treatment and prevention of parastomal hernias
DK2375907T3 (da) *	2008-11-21	2019-06-11	Celularity Inc	Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
JPWO2010064702A1 (ja) *	2008-12-05	2012-05-10	国立大学法人東京大学	癌の予後を予測するためのバイオマーカー
US20110245804A1 (en)	2008-12-05	2011-10-06	Regenerative Sciences, Llc	Methods and Compositions to Facilitate Repair of Avascular Tissue
US8366748B2 (en)	2008-12-05	2013-02-05	Kleiner Jeffrey	Apparatus and method of spinal implant and fusion
US20100168022A1 (en) *	2008-12-11	2010-07-01	Centeno Christopher J	Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
JP5518893B2 (ja) *	2008-12-19	2014-06-11	アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー	肺ならびに肺の疾患および障害の治療
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US20130302283A1 (en) *	2012-05-14	2013-11-14	Advanced Technologies And Regenerative Medicine, Llc	hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
EP2379087B1 (en) *	2008-12-19	2014-08-20	DePuy Synthes Products, LLC	Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
CN102458425A (zh) *	2008-12-19	2012-05-16	伊西康公司	损伤后神经组织的再生和修复
US8771677B2 (en) *	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
KR20110107357A (ko) *	2008-12-30	2011-09-30	케이씨아이 라이센싱 인코포레이티드	연골 회복을 위한 미세골절 수술의 감압 증대
JP5701614B2 (ja) *	2009-01-23	2015-04-15	国立大学法人東京大学	培養細胞の評価方法
US9247943B1 (en)	2009-02-06	2016-02-02	Kleiner Intellectual Property, Llc	Devices and methods for preparing an intervertebral workspace
WO2010093976A1 (en) *	2009-02-12	2010-08-19	University Of Southern California	Bioadhesive patch for sutureless closure of soft tissue
KR101422690B1 (ko) *	2009-02-27	2014-07-23	(주)차바이오앤디오스텍	배아줄기세포 유래 혈관형성전구세포의 배양 분비물을 포함하는 피부재생용 조성물 및 이의 용도
CN102439136A (zh) *	2009-03-26	2012-05-02	加州大学校董	产生用于疾病修饰的抑制性rna的间充质干细胞
EP2411504B1 (en) *	2009-03-26	2017-05-10	DePuy Synthes Products, Inc.	Human umbilical cord tissue cells as therapy for alzheimer's disease
WO2010118059A1 (en) *	2009-04-06	2010-10-14	Capricor, Inc.	Systems and methods for cardiac tissue repair
EP2431460B1 (en) *	2009-05-13	2015-10-14	Medipost, Co., Ltd.	Tsp-1, tsp-2 and il-17br associated with stem cell differentiation
US20110020271A1 (en) *	2009-05-20	2011-01-27	Humacyte, Inc.	Elastin for soft tissue augmentation
EP2434896A4 (en) *	2009-05-28	2014-01-22	Univ Central Florida Res Found	IN VITRO PRODUCTION OF OLIGODIAN DROCYTES FROM HEMAN NAIL CORD STEM CELLS
US20150335400A1 (en) *	2009-06-17	2015-11-26	The Trustees Of Columbia University In The City Of New York	Tooth scaffolds
US8647617B2 (en)	2009-07-13	2014-02-11	Stemnion, Inc.	Methods for modulating inflammatory and/or immune responses
SG177483A1 (en) *	2009-07-20	2012-02-28	Janssen Biotech Inc	Differentiation of human embryonic stem cells
EP2456859A4 (en) *	2009-07-20	2015-03-18	Janssen Biotech Inc	DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
KR102058901B1 (ko)	2009-07-20	2019-12-24	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 분화
SG178064A1 (en) *	2009-07-21	2012-03-29	Abt Holding Co	Use of stem cells to reduce leukocyte extravasation
ES2360434B1 (es)	2009-07-21	2012-04-12	Universitat Internacional De Catalunya	Celulas madre pluripotenciales obtenidas a partir de la pulpa dental.
WO2011022070A2 (en) *	2009-08-20	2011-02-24	The Regents Of The University Of California	Perivascular stem cell composition for bone
US20110054929A1 (en) *	2009-09-01	2011-03-03	Cell Solutions Colorado Llc	Stem Cell Marketplace
US8207651B2 (en)	2009-09-16	2012-06-26	Tyco Healthcare Group Lp	Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point
US9060877B2 (en)	2009-09-18	2015-06-23	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US10245159B1 (en)	2009-09-18	2019-04-02	Spinal Surgical Strategies, Llc	Bone graft delivery system and method for using same
US8685031B2 (en)	2009-09-18	2014-04-01	Spinal Surgical Strategies, Llc	Bone graft delivery system
US9173694B2 (en)	2009-09-18	2015-11-03	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
US20170238984A1 (en)	2009-09-18	2017-08-24	Spinal Surgical Strategies, Llc	Bone graft delivery device with positioning handle
US8906028B2 (en)	2009-09-18	2014-12-09	Spinal Surgical Strategies, Llc	Bone graft delivery device and method of using the same
US10973656B2 (en)	2009-09-18	2021-04-13	Spinal Surgical Strategies, Inc.	Bone graft delivery system and method for using same
US9629729B2 (en)	2009-09-18	2017-04-25	Spinal Surgical Strategies, Llc	Biological delivery system with adaptable fusion cage interface
US9186193B2 (en)	2009-09-18	2015-11-17	Spinal Surgical Strategies, Llc	Fusion cage with combined biological delivery system
USD723682S1 (en)	2013-05-03	2015-03-03	Spinal Surgical Strategies, Llc	Bone graft delivery tool
USD750249S1 (en)	2014-10-20	2016-02-23	Spinal Surgical Strategies, Llc	Expandable fusion cage
CN102686722B (zh) *	2009-09-23	2014-11-05	达芬奇生物科技有限责任公司	脐带衬干细胞及其分离和培养方法和材料
ES2609006T3 (es)	2009-10-16	2017-04-18	Rutgers, The State University Of New Jersey	Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
ES2665006T3 (es) *	2009-10-29	2018-04-24	Janssen Biotech, Inc.	Células madre pluripotentes
WO2011053874A1 (en)	2009-10-30	2011-05-05	Tandem Abela Development Group Llc	Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
US9113950B2 (en)	2009-11-04	2015-08-25	Regenerative Sciences, Llc	Therapeutic delivery device
US20130028978A1 (en) *	2009-11-10	2013-01-31	The Trustees Of Columbia University In The City Of New York	Compositions and methods for wound treatment
US20130129686A1 (en) *	2009-11-19	2013-05-23	Regents Of The University	Reducing Inflammation Using Cell Therapy
US20140286911A1 (en)	2013-03-15	2014-09-25	Allosource	Cell repopulated collagen matrix for soft tissue repair and regeneration
SG181687A1 (en)	2009-12-23	2012-07-30	Centocor Ortho Biotech Inc	Differentiation of human embryonic stem cells
CA2784425A1 (en) *	2009-12-23	2011-06-30	Centocor Ortho Biotech Inc.	Differentiation of human embryonic stem cells
EP2528608B1 (en)	2010-01-26	2015-12-16	Stem Cells Spin S.A.	Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use
DK3284818T3 (da) *	2010-01-26	2022-06-20	Celularity Inc	Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
EP3351625A1 (en)	2010-02-18	2018-07-25	Osiris Therapeutics, Inc.	Methods of manufacture of immunocompatible amniotic membrane products
CN102753105B (zh) *	2010-02-19	2015-09-30	生命细胞公司	腹壁治疗装置
CN102811622A (zh)	2010-02-22	2012-12-05	生物模拟治疗公司	用于治疗腱病的血小板衍生生长因子组合物和方法
EP2542667A4 (en)	2010-03-01	2013-07-31	Janssen Biotech Inc	PROCESS FOR CLEANING CELLS OBTAINED FROM PLURIPOTENTIAL STEM CELLS
DK2556145T3 (en)	2010-04-07	2016-11-07	Anthrogenesis Corp	Angiogenesis using placental stem cells
EP2555783A1 (en)	2010-04-08	2013-02-13	Anthrogenesis Corporation	Treatment of sarcoidosis using placental stem cells
US9845457B2 (en)	2010-04-30	2017-12-19	Cedars-Sinai Medical Center	Maintenance of genomic stability in cultured stem cells
US8529883B2 (en)	2010-05-07	2013-09-10	Fibrocell Technologies, Inc.	Dosage unit formulations of autologous dermal fibroblasts
RU2663339C1 (ru)	2010-05-12	2018-08-03	Янссен Байотек, Инк.	Дифференцирование эмбриональных стволовых клеток человека
US8883210B1 (en)	2010-05-14	2014-11-11	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en)	2010-05-14	2016-05-31	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en)	2010-05-14	2018-11-20	Musculoskeletal Transplant Foundation	Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2011153236A1 (en) *	2010-06-03	2011-12-08	The Board Of Trustees Of The Leland Stanford Junior University	Purified compositions of cardiovascular progenitor cells
EP3192862B1 (en)	2010-07-02	2021-04-07	The University of North Carolina at Chapel Hill	Biomatrix scaffolds
AU2011279250B2 (en)	2010-07-12	2014-12-04	California Institute Of Technology	Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
US8825388B2 (en)	2010-07-13	2014-09-02	Qualcomm Incorporated	Indoor likelihood heatmap
MX342995B (es)	2010-07-13	2016-10-21	Anthrogenesis Corp	Métodos de generar células asesinas naturales.
JP2012031127A (ja) *	2010-08-03	2012-02-16	Nagoya Univ	臍帯由来間葉系幹細胞を含む組成物
US20130203146A1 (en) *	2010-08-03	2013-08-08	Jackie Y. Ying	Microfabricated scaffold structures
IL207586A0 (en)	2010-08-12	2010-12-30	Omrix Biopharmaceuticals Ltd	A fibrin based therapeutic preparation and use thereof
WO2012021885A1 (en) *	2010-08-13	2012-02-16	The Trustees Of Columbia University In The City Of New York	Three-dimensional tissue engineering devices and uses thereof
CN103221536B (zh)	2010-08-31	2016-08-31	詹森生物科技公司	人胚胎干细胞的分化
EP2611907B1 (en)	2010-08-31	2016-05-04	Janssen Biotech, Inc.	Differentiation of pluripotent stem cells
ES2658146T3 (es)	2010-08-31	2018-03-08	Janssen Biotech, Inc.	Diferenciación de células madre embrionarias humanas
WO2012030968A1 (en) *	2010-08-31	2012-03-08	Renovocyte, LLC	Systemic, allogenic stem cell therapies for treatment of diseases in animals
EP2625264B1 (en)	2010-10-08	2022-12-07	Terumo BCT, Inc.	Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US8546338B2 (en)	2010-12-08	2013-10-01	Johnson & Johnson Consumer Companies, Inc.	Self-assembling hydrogels based on dicephalic peptide amphiphiles
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
WO2012092485A1 (en)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory rna molecules
JP5388233B2 (ja) *	2011-01-19	2014-01-15	富士ソフト株式会社	再生軟骨の軟骨特性を評価する方法
US12093036B2 (en)	2011-01-21	2024-09-17	Teladoc Health, Inc.	Telerobotic system with a dual application screen presentation
US8945536B2 (en) *	2011-01-26	2015-02-03	The Chinese University Of Hong Kong	Stem cell sheet for tissue repair
US9044430B2 (en)	2011-03-18	2015-06-02	Microvascular Tissues, Inc.	Allogeneic microvascular tissue for soft tissue treatments
KR101903339B1 (ko)	2011-03-22	2018-10-01	플루리스템 리미티드	방사선 또는 화학적 손상을 치료하는 방법
US9526770B2 (en)	2011-04-28	2016-12-27	Tissuetech, Inc.	Methods of modulating bone remodeling
WO2012148397A1 (en)	2011-04-28	2012-11-01	Aquero Company, Llc	Lysine-based polymer coagulants for use in clarification of process waters
US8877489B2 (en)	2011-12-05	2014-11-04	California Institute Of Technology	Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en)	2011-04-29	2019-11-19	University Of Southern California	Instruments and methods for the implantation of cell-seeded substrates
US8834928B1 (en)	2011-05-16	2014-09-16	Musculoskeletal Transplant Foundation	Tissue-derived tissugenic implants, and methods of fabricating and using same
AU2012262311B2 (en) *	2011-05-31	2016-04-28	Lifecell Corporation	Adipose tissue matrices
ES2707579T3 (es)	2011-06-01	2019-04-04	Celularity Inc	Tratamiento del dolor usando citoblastos placentarios
ES2822301T3 (es)	2011-06-10	2021-04-30	Tissuetech Inc	Métodos de procesamiento de tejidos de soporte fetal
US20140189897A1 (en)	2011-06-21	2014-07-03	Mayo Foundation For Medical Education And Research	Transgenic animals capable of being induced to delete senescent cells
AU2012275335B2 (en)	2011-06-29	2017-04-20	Biorestorative Therapies, Inc.	Brown fat cell compositions and methods
US20130005829A1 (en)	2011-06-30	2013-01-03	Advanced Technologies And Regenerative Medicine, Llc.	Segmented, epsilon-Caprolactone-Rich, Poly(epsilon-Caprolactone-co-p-Dioxanone) Copolymers for Medical Applications and Devices Therefrom
WO2013010045A1 (en)	2011-07-12	2013-01-17	Biotime Inc.	Novel methods and formulations for orthopedic cell therapy
BR112014003071A2 (pt) *	2011-08-10	2017-02-21	Depuy Synthes Products Llc	tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
WO2013055476A1 (en)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Treatment of amyotrophic lateral sclerosis using placental stem cells
US9248013B2 (en)	2011-12-05	2016-02-02	California Institute Of Technology	3-Dimensional parylene scaffold cage
KR20140119023A (ko)	2011-12-13	2014-10-08	버크 인스티튜트 포 리서치 온 에이징	의료 요법을 개선하는 방법
US9162011B2 (en)	2011-12-19	2015-10-20	Allosource	Flowable matrix compositions and methods
US20130157365A1 (en) *	2011-12-20	2013-06-20	Advanced Technologies And Regenerative Medicine, Llc	Induced pluripotent stem cells from human umbilical cord tissue-derived cells
ES2729712T3 (es)	2011-12-20	2019-11-05	Lifecell Corp	Productos de tejido de lámina
WO2013096252A1 (en)	2011-12-20	2013-06-27	Lifecell Corporation	Flowable tissue products
KR102203056B1 (ko)	2011-12-22	2021-01-14	얀센 바이오테크 인코포레이티드	인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
EP2794854B1 (en)	2011-12-23	2018-06-20	DePuy Synthes Products, Inc.	Detection of human umbilical cord tissue-derived cells
HUE056817T2 (hu)	2011-12-30	2022-03-28	Amit Patel	Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások
EP2806907B1 (en)	2012-01-24	2018-11-21	LifeCell Corporation	Elongated tissue matrices
US9575054B2 (en) *	2012-02-23	2017-02-21	Anthrogenesis Corporation	Identification of antitumor compounds using placenta
US8940294B2 (en)	2012-03-02	2015-01-27	Tissuetech, Inc.	Methods of isolating and culturing stem cells
HK1206058A1 (en)	2012-03-07	2015-12-31	Janssen Biotech, Inc.	Defined media for expansion and maintenance of pluripotent stem cells
US20150064137A1 (en)	2012-04-17	2015-03-05	Kythera Biopharmaceuticals, Inc.	Use of engineered viruses to specifically kill senescent cells
US9999637B2 (en)	2012-04-24	2018-06-19	Lifecell Corporation	Functionalized tissue matrices
WO2013184527A1 (en)	2012-06-05	2013-12-12	Capricor, Inc.	Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
AU2013271581B2 (en)	2012-06-08	2018-08-09	Janssen Biotech, Inc.	Differentiation of human embryonic stem cells into pancreatic endocrine cells
EP2869903B1 (en)	2012-07-06	2018-11-28	3-D Matrix Ltd.	Fill-finish process for peptide solutions
EP2870173B1 (en)	2012-07-09	2018-10-17	Roche Diagniostics GmbH	Recombinantly produced neutral protease originating from paenibacillus polymyxa
US11090338B2 (en)	2012-07-13	2021-08-17	Lifecell Corporation	Methods for improved treatment of adipose tissue
US8960674B2 (en)	2012-07-27	2015-02-24	Bally Gaming, Inc.	Batch card shuffling apparatuses including multi-card storage compartments, and related methods
AU2013302799B2 (en)	2012-08-13	2018-03-01	Cedars-Sinai Medical Center	Exosomes and micro-ribonucleic acids for tissue regeneration
US9901081B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse for determining the role of senescent cells in cancer
US9901080B2 (en)	2012-08-23	2018-02-27	Buck Institute For Research On Aging	Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9872937B2 (en)	2012-09-19	2018-01-23	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US10596202B2 (en)	2012-09-19	2020-03-24	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
US11819522B2 (en)	2012-09-19	2023-11-21	Microvascular Tissues, Inc.	Compositions and methods for treating and preventing tissue injury and disease
ES2710921T3 (es)	2012-09-19	2019-04-29	Microvascular Tissues Inc	Composiciones para tratar y prevenir lesión y enfermedad tisular
US9370536B2 (en)	2012-09-26	2016-06-21	Lifecell Corporation	Processed adipose tissue
WO2014051398A1 (ko) *	2012-09-28	2014-04-03	한국생명공학연구원	아세카이니드 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
ITTO20120859A1 (it) *	2012-10-02	2014-04-03	Univ Degli Studi Torino	Nuova applicazione terapeutica di un mezzo condizionato da cellule staminali mesenchimali placentari
WO2014066649A1 (en) *	2012-10-26	2014-05-01	The Regents Of The University Of California	A strategy for engineering various 3d tissues, organoids and vasculature
US10279018B2 (en)	2012-12-03	2019-05-07	Unity Biotechnology, Inc.	Immunogenic compositions for inducing an immune response for elimination of senescent cells
US20140170748A1 (en) *	2012-12-14	2014-06-19	DePuy Synthes Products, LLC	Nutrient Enriched Media for hUTC Growth
US10370644B2 (en)	2012-12-31	2019-08-06	Janssen Biotech, Inc.	Method for making human pluripotent suspension cultures and cells derived therefrom
BR112015015770A2 (pt)	2012-12-31	2017-07-11	Janssen Biotech Inc	cultivo de células-tronco embrionárias humanas na interface ar-líquido para diferenciação em células pancreáticas endócrinas
JP6557147B2 (ja)	2012-12-31	2019-08-07	ヤンセンバイオテツク，インコーポレーテツド	Ｈｂ９調節物を用いたヒト胚性幹細胞の膵臓内分泌細胞への分化
RU2687379C2 (ru)	2012-12-31	2019-05-13	Янссен Байотек, Инк.	Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
EP2756754B1 (de)	2013-01-17	2017-01-04	Vita 34 Ag	Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
US20140212390A1 (en) *	2013-01-30	2014-07-31	NuTech Medical, Inc.	Placental Membrane Preparation and Methods of Making and Using Same
AU2014215458A1 (en)	2013-02-05	2015-08-13	Anthrogenesis Corporation	Natural killer cells from placenta
US9867939B2 (en)	2013-03-12	2018-01-16	Allergan, Inc.	Adipose tissue combinations, devices, and uses thereof
AU2014248873B2 (en)	2013-03-13	2017-03-23	Allosource	Fascia fibrous compositions and methods for their use and manufacture
US10329529B2 (en)	2013-03-14	2019-06-25	Celularity, Inc.	Enhanced placental stem cells and uses thereof
RU2539750C2 (ru) *	2013-04-09	2015-01-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ оценки иммуносупрессивных свойств мезенхимальных стромальных клеток человека
US20140350516A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Mechanical syringe accessory
US11229789B2 (en)	2013-05-30	2022-01-25	Neurostim Oab, Inc.	Neuro activator with controller
WO2014194200A1 (en)	2013-05-30	2014-12-04	Creasey Graham H	Topical neurological stimulation
US10058572B2 (en)	2013-08-15	2018-08-28	The Regents Of The University Of California	Placenta-derived multipotent stem cells
US9248384B2 (en)	2013-10-02	2016-02-02	Allergan, Inc.	Fat processing system
JP6633522B2 (ja)	2013-11-16	2020-01-22	テルモビーシーティー、インコーポレーテッド	バイオリアクターにおける細胞増殖
KR101832203B1 (ko)	2013-12-06	2018-02-27	알로소스	조직의 시트를 건조하는 방법
GB2536174B (en) *	2013-12-17	2020-12-16	Dtherapeutics Llc	Devices, systems and methods for tissue engineering of luminal grafts
US20170216286A1 (en)	2014-01-28	2017-08-03	Mayo Foundation For Medical Education And Research	Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid
AU2015211021B2 (en)	2014-01-28	2020-07-02	Buck Institute For Research On Aging	Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10328058B2 (en)	2014-01-28	2019-06-25	Mayo Foundation For Medical Education And Research	Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
US20190269675A1 (en)	2014-01-28	2019-09-05	Buck Institute for Research and Aging	Treatment of parkinson's disease and other conditions caused or mediated by senescent astrocytes using small molecule senolytic agents
WO2015126694A1 (en)	2014-02-12	2015-08-27	Ethicon Endo-Surgery, Inc.	Method and apparatus for suprachoroidal administration of therapeutic agent
WO2015136370A2 (en)	2014-03-10	2015-09-17	3-D Matrix, Ltd.	Sterilization and filtration of peptide compositions
AU2015229549B2 (en)	2014-03-10	2019-05-23	3-D Matrix, Ltd.	Self-assembling peptide compositions
WO2015148704A1 (en)	2014-03-25	2015-10-01	Terumo Bct, Inc.	Passive replacement of media
JP2017514876A (ja) *	2014-05-07	2017-06-08	オシリスセラピューティクス，インコーポレイテッド	治療用胎盤組成物、その製造法及び使用法
WO2015170347A2 (en)	2014-05-09	2015-11-12	Reelabs Private Limited	Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
US10006006B2 (en)	2014-05-16	2018-06-26	Janssen Biotech, Inc.	Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
US9925088B2 (en)	2014-06-06	2018-03-27	Janssen Biotech, Inc.	Sub-retinal tangential needle catheter guide and introducer
US9949874B2 (en)	2014-06-06	2018-04-24	Janssen Biotech, Inc.	Therapeutic agent delivery device with convergent lumen
US20160000550A1 (en) *	2014-07-05	2016-01-07	Deborah Nagle	Methods for treating diseases of the colon
CN106661552B (zh) *	2014-07-11	2020-07-07	玛土撤拉有限公司	心脏细胞培养材料
US10064752B2 (en)	2014-09-11	2018-09-04	Orbit Biomedical Limited	Motorized suprachoroidal injection of therapeutic agent
US10219936B2 (en)	2014-09-11	2019-03-05	Orbit Biomedical Limited	Therapeutic agent delivery device with advanceable cannula and needle
US10322028B2 (en)	2014-09-11	2019-06-18	Orbit Biomedical Limited	Method and apparatus for sensing position between layers of an eye
WO2016044681A1 (en)	2014-09-18	2016-03-24	North Carolina State University	Mammalian lung spheroids and lung spheroid cells and uses thereof
US10258502B2 (en)	2014-09-18	2019-04-16	Orbit Biomedical Limited	Therapeutic agent delivery device
US9504905B2 (en)	2014-09-19	2016-11-29	Bally Gaming, Inc.	Card shuffling device and calibration method
KR101613478B1 (ko) *	2014-09-22	2016-04-19	(주)안트로젠	중간엽줄기세포-하이드로겔을 함유하는 조성물 및 이의 제조방법
US20160090569A1 (en)	2014-09-26	2016-03-31	Terumo Bct, Inc.	Scheduled Feed
CA2962444C (en)	2014-10-03	2023-09-05	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
MX2017004520A (es)	2014-10-14	2018-03-15	Lynch Samuel	Composiciones para tratar heridas.
WO2016068616A1 (ko) *	2014-10-29	2016-05-06	차의과학대학교 산학협력단	C3 또는 c1r 보체를 분비하는 태반 유래 세포 및 이를 포함하는 조성물
US10709811B2 (en) *	2014-10-31	2020-07-14	The Administrators Of The Tulane Educational Fund	Surgical grafts for replacing the nipple and areola or damaged epidermis
JP6683700B2 (ja)	2014-11-07	2020-04-22	株式会社エキソステムテックＥｘｏｓｔｅｍｔｅｃｈＣｏ．，Ｌｔｄ．	幹細胞由来のエキソソームを含有する脂肪細胞分化誘導、または脂肪組織の再生用組成物の製造方法
JP2017537702A (ja) *	2014-12-05	2017-12-21	ヤンセンバイオテツク，インコーポレーテツド	前駆細胞を用いた眼球症状の治療法
CN106471371B (zh) *	2014-12-05	2018-05-04	宣捷生物科技股份有限公司	区别间充质干细胞的方法
US20170080033A1 (en) *	2014-12-16	2017-03-23	Janssen Biotech, Inc.	Treatment of retinal degeneration using progenitor cells
BR112017012581A2 (pt) *	2014-12-16	2017-12-26	Janssen Biotech Inc	tratamento de degeneração da retina com o uso de células progenitoras
AU2015363008B2 (en)	2014-12-19	2021-12-09	Janssen Biotech, Inc.	Suspension culturing of pluripotent stem cells
WO2016111899A1 (en)	2015-01-05	2016-07-14	Petrucci Gary M	Methods and materials for treating lung disorders
WO2016126122A2 (ko) *	2015-02-04	2016-08-11	한양대학교 에리카산학협력단	연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
US11077301B2 (en)	2015-02-21	2021-08-03	NeurostimOAB, Inc.	Topical nerve stimulator and sensor for bladder control
US20160243288A1 (en)	2015-02-23	2016-08-25	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
CN107567494A (zh)	2015-03-04	2018-01-09	迈索布拉斯特国际有限公司	间充质干细胞的细胞培养方法
AU2016229013B2 (en)	2015-03-10	2020-05-21	Allergan Sales, Llc	Multiple needle injector
CA2979293C (en)	2015-03-11	2022-01-04	Timothy J. Kieffer	Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (t2d)
JP2018510005A (ja)	2015-03-31	2018-04-12	ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル	幹細胞の送達媒体およびその使用
US10709428B2 (en) *	2015-05-01	2020-07-14	Dermtech, Inc.	Non-invasive skin collection system
US10286009B2 (en) *	2015-05-16	2019-05-14	Asterias Biotherapeutics, Inc.	Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury
JP2018516869A (ja)	2015-05-20	2018-06-28	ティッシュテック，インク．	上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
CA3177726A1 (en)	2015-05-21	2016-11-24	Musculoskeletal Transplant Foundation	Modified demineralized cortical bone fibers
US10335435B2 (en)	2015-05-22	2019-07-02	Marco Merida	Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
US10384207B2 (en)	2015-07-21	2019-08-20	Neuro Probe Incorporated	Assay apparatus and methods
WO2017019832A1 (en)	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Methods and compositions using repair cells and cationic dyes
WO2017019822A1 (en) *	2015-07-29	2017-02-02	Medivation Technologies, Inc.	Pellet composition containing repair cells
JP6998768B2 (ja)	2015-08-28	2022-02-10	ロート製薬株式会社	Ｒｏｒ１陽性の間葉系幹細胞及びその調製方法、ｒｏｒ１陽性の間葉系幹細胞を含む医薬組成物及びその調製方法、並びにｒｏｒ１陽性の間葉系幹細胞を用いる疾患の予防又は治療方法
USD797290S1 (en)	2015-10-19	2017-09-12	Spinal Surgical Strategies, Llc	Bone graft delivery tool
US11384328B2 (en)	2015-11-18	2022-07-12	President And Fellows Of Harvard College	Cartridge-based system for long term culture of cell clusters
US12551509B2 (en)	2015-11-18	2026-02-17	Lucina Patent Holdco, Llc	Acellular regenerative products and methods of their manufacture
BR112018011278A2 (pt) *	2015-12-04	2018-11-21	Janssen Biotech Inc	tratamento de degeneração da retina com o uso de células progenitoras
KR20170076484A (ko) *	2015-12-24	2017-07-04	삼성전자주식회사	프로토카데린의 과발현을 이용한 노화 세포를 분리하는 방법
US10814038B2 (en)	2016-01-06	2020-10-27	3-D Matrix, Ltd.	Combination compositions
EP3402543B1 (en)	2016-01-11	2021-09-08	Cedars-Sinai Medical Center	Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US10791730B2 (en)	2016-01-14	2020-10-06	DePuy Synthes Products, Inc.	Composition and methods for cryopreservation of hUTC
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
US10993969B2 (en)	2016-02-05	2021-05-04	Gary M. Petrucci	Methods and materials for treating nerve injuries and neurological disorders
US11458224B2 (en) *	2016-03-04	2022-10-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Ovarian-derived hydrogels for biomedical and biotechnology applications
US10478553B2 (en)	2016-03-09	2019-11-19	Orbit Biomedical Limited	Apparatus for subretinal administration of therapeutic agent via a curved needle
GB201604304D0 (en)	2016-03-14	2016-04-27	Tigenix S A U	Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3223181B1 (en) *	2016-03-24	2019-12-18	Sofradim Production	System and method of generating a model and simulating an effect on a surgical repair site
CN116121189A (zh)	2016-03-30	2023-05-16	阿斯特利亚斯生物治疗股份公司	少突胶质细胞祖细胞组合物
RU2725968C2 (ru)	2016-04-08	2020-07-07	Аллерган, Инк.	Аспирационно-инъекционное устройство
DK3443073T3 (da)	2016-04-14	2024-09-02	Janssen Biotech Inc	Differentiering af pluripotente stamceller til intestinale mellemtarmendodermceller
EP3450548A4 (en)	2016-04-27	2019-11-20	Rohto Pharmaceutical Co., Ltd.	MESCHYMAL STEM CELL FOR EXPRESSING AT LEAST ONE CELL SURFACE MARKER SELECTED FROM THE GROUP OF CD201, CD46, CD56, CD147 AND CD165, AND METHOD FOR THE MANUFACTURE THEREOF AND PHARMACEUTICAL COMPOSITION WITH THE MESENCHYMAL STEM CELL AND METHOD FOR THE PRODUCTION THEREOF
JP7034949B2 (ja)	2016-05-25	2022-03-14	テルモビーシーティー、インコーポレーテッド	細胞の増殖
WO2017210652A1 (en)	2016-06-03	2017-12-07	Cedars-Sinai Medical Center	Cdc-derived exosomes for treatment of ventricular tachyarrythmias
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
US11000410B2 (en)	2016-06-17	2021-05-11	Gyroscope Therapeutics Limited	Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en)	2016-06-17	2020-05-12	Orbit Biomedical Limited	Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
US10806629B2 (en)	2016-06-17	2020-10-20	Gyroscope Therapeutics Limited	Injection device for subretinal delivery of therapeutic agent
WO2017222879A1 (en)	2016-06-21	2017-12-28	Janssen Biotech, Inc.	Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
MX2019000050A (es)	2016-07-05	2019-05-02	Janssen Biotech Inc	Tratamiento de la enfermedad vascular retinal mediante el uso de celulas progenitoras.
US10639398B2 (en)	2016-07-05	2020-05-05	Lifecell Corporation	Tissue matrices incorporating multiple tissue types
CN109715091A (zh) *	2016-08-19	2019-05-03	雷金蒂斯公司	用于粘膜组织的组织重建的细胞外基质
EP3405204B1 (en) *	2016-08-26	2025-06-25	Restem Llc	Composition and methods of using umbilical cord lining stem cells
US11541078B2 (en)	2016-09-20	2023-01-03	Cedars-Sinai Medical Center	Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
PT3534981T (pt) *	2016-11-02	2026-03-10	Axogen Corp	Enxertos de tecido amniótico e métodos de preparação e utilização dos mesmos
RU2644306C1 (ru) *	2016-11-22	2018-02-08	Общество с ограниченной ответственностью "ДЖИ-Групп"	Способ восстановления дефектов покровных тканей
WO2018125851A1 (en) *	2016-12-26	2018-07-05	Michael Moeller	Systems and methods to isolate and expand stem cells from urine
US11273072B2 (en)	2017-01-13	2022-03-15	Gyroscope Therapeutics Limited	Suprachoroidal injection device
US10772986B2 (en)	2017-01-26	2020-09-15	Allosource	Fascia fibrous compositions and methods for their use and manufacture
US20200069740A1 (en)	2017-03-08	2020-03-05	Rohto Pharmaceutical Co., Ltd.	Ror1-positive mesenchymal stem cell-containing pharmaceutical composition for preventing or treating disease associated with fibrosis, method for preparing same, and method for preventing or treating disease associated with fibrosis using ror1-positive mesenchymal stem cells
US11076984B2 (en)	2017-03-13	2021-08-03	Gyroscope Therapeutics Limited	Method of performing subretinal drainage and agent delivery
WO2018170394A1 (en) *	2017-03-17	2018-09-20	Rutgers, The State University Of New Jersey	Compositions and methods for wound healing
US10767164B2 (en)	2017-03-30	2020-09-08	The Research Foundation For The State University Of New York	Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN117247899A (zh)	2017-03-31	2023-12-19	泰尔茂比司特公司	细胞扩增
US12234441B2 (en)	2017-03-31	2025-02-25	Terumo Bct, Inc.	Cell expansion
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
EP4317422A3 (en)	2017-04-13	2024-05-01	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
EP4699658A2 (en)	2017-04-19	2026-02-25	Cedars-Sinai Medical Center	Methods and compositions for treating skeletal muscular dystrophy
US10478531B2 (en)	2017-06-22	2019-11-19	Gary M. Petrucci	Methods and materials for treating blood vessels
CA3067109A1 (en) *	2017-06-29	2019-01-03	Xintela Ab	Quality assurance of chondrocytes
JP7195033B2 (ja)	2017-07-18	2022-12-23	ザリサーチファウンデイションフォーザステイトユニバーシティーオブニューヨーク	頭蓋内動脈瘤のためのバイオマーカー
US10251917B1 (en)	2017-09-19	2019-04-09	Gary M. Petrucci	Methods and materials for treating tumors
WO2019079570A1 (en)	2017-10-18	2019-04-25	Lifecell Corporation	ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION
US11123375B2 (en)	2017-10-18	2021-09-21	Lifecell Corporation	Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en)	2017-10-19	2022-02-15	Lifecell Corporation	Methods for introduction of flowable acellular tissue matrix products into a hand
WO2019079672A1 (en)	2017-10-19	2019-04-25	Lifecell Corporation	ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
US11629318B2 (en)	2017-10-20	2023-04-18	President And Fellows Of Harvard College	Methods for producing mature adipocytes and methods of use thereof
US20210038650A1 (en) *	2017-10-23	2021-02-11	Cell Medicine, Inc.	Mesenchymal stem cell therapy of leigh syndrome
TW201932126A (zh) *	2017-11-03	2019-08-16	美商健生生物科技公司	抑制血管生成之方法
EP3706856A4 (en)	2017-11-07	2021-08-18	Neurostim Oab, Inc.	NON-INVASIVE NERVOUS ACTIVATOR WITH ADAPTIVE CIRCUIT
US11660355B2 (en)	2017-12-20	2023-05-30	Cedars-Sinai Medical Center	Engineered extracellular vesicles for enhanced tissue delivery
US11285177B2 (en)	2018-01-03	2022-03-29	Globus Medical, Inc.	Allografts containing viable cells and methods thereof
WO2019139137A1 (ja)	2018-01-12	2019-07-18	国立大学法人大阪大学	重層扁平上皮細胞の正常分化・成熟促進剤、上皮疾患治療剤及び重層扁平上皮細胞の正常分化・成熟促進方法
US20190218521A1 (en) *	2018-01-18	2019-07-18	Lorenzo Bracco	Culture medium of viruses for human vaccines have to consist of human cells from placenta and/or from umbilical cord of a fetus of the blood type 0 Rh- and of the mother of the blood type 0 Rh- (both, fetus and mother, must be of the blood type 0 Rh-)
US20200360563A1 (en) *	2018-01-30	2020-11-19	University Of Georgia Research Foundation, Inc.	Methods for Vascular Construction and Products Therefrom
US12146137B2 (en)	2018-02-05	2024-11-19	Cedars-Sinai Medical Center	Methods for therapeutic use of exosomes and Y-RNAS
CN108384752A (zh) *	2018-02-13	2018-08-10	中国人民解放军第四五五医院	成软骨培养基及其在微分裂技术中膝关节软骨分化中的应用
JP2021526556A (ja) *	2018-05-30	2021-10-07	ダイレクトバイオロジクスエルエルシー	成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法
CN108961233A (zh) *	2018-06-28	2018-12-07	华侨大学	一种聚晶金刚石复合片表面缺陷分类识别方法
IL281628B2 (en)	2018-09-19	2025-06-01	Lineage Cell Therapeutics Inc	Methods for differentiating pluripotent stem cells in dynamic suspension culture
US11419898B2 (en)	2018-10-17	2022-08-23	Senti Biosciences, Inc.	Combinatorial cancer immunotherapy
SG11202103317XA (en)	2018-10-17	2021-05-28	Senti Biosciences Inc	Combinatorial cancer immunotherapy
WO2020154533A1 (en)	2019-01-23	2020-07-30	Asterias Biotherapeutics, Inc.	Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
BR112021015549A2 (pt)	2019-02-07	2021-10-26	Direct Biologics Llc	Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes
US12391924B2 (en)	2019-02-08	2025-08-19	Regrow Biosciences Private Limited	Method for mesenchymal stem cell isolation and osteoblast differentiation
US11759355B1 (en)	2019-02-26	2023-09-19	Gyroscope Therapeutics Limited	Method of delivering leading blebs and agent to subretinal space
KR102169924B1 (ko) *	2019-03-26	2020-10-26	연세대학교 산학협력단	연골세포 분화 유도용 조성물 및 이의 용도
KR102167257B1 (ko) *	2019-05-28	2020-10-19	부산대학교 산학협력단	토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법
ES3056561T3 (en)	2019-05-30	2026-02-23	Lifecell Corp	Biologic breast implant
US11458311B2 (en)	2019-06-26	2022-10-04	Neurostim Technologies Llc	Non-invasive nerve activator patch with adaptive circuit
CA3146433A1 (en)	2019-07-18	2021-01-21	Direct Biologics Llc	Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CA3152505A1 (en)	2019-08-29	2021-03-04	Ajinomoto Co., Inc.	Method for producing mesenchymal stem cells from living body-derived cell sample containing mesenchymal stem cells
US20220330530A1 (en) *	2019-09-13	2022-10-20	The University Of North Carolina At Chapel Hill	Method of making human mouse xenografts
EP4041260A4 (en) *	2019-10-07	2023-11-01	University of Utah Research Foundation	HUMAN CHONDROGENIC MESENCHYMAL STEM CELL (MSC) SHEETS
IL292024B1 (en)	2019-10-11	2026-01-01	Gyroscope Therapeutics Ltd	Syringe Dosing Cartridge Assembly
WO2021092199A1 (en)	2019-11-08	2021-05-14	Kansas State University Research Foundation	Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
TWI776276B (zh) *	2019-11-13	2022-09-01	中國醫藥大學	異種組織細胞組合物治療癌症之用途
KR20220115802A (ko)	2019-12-16	2022-08-18	뉴로스팀 테크놀로지스 엘엘씨	부스트 전하 전달 기능이 있는 비침습적 신경 액티베이터
US12590310B2 (en)	2020-04-22	2026-03-31	Direct Biologics, Llc	Methods and compositions for treating inflammatory conditions associated with infectious disease
EP4146787A4 (en)	2020-05-08	2024-06-26	Gallant Pet, Inc.	Uterine-derived regenerative cell compositions and uses thereof
CN111718410B (zh) *	2020-06-05	2022-10-11	江南大学	一种制备卵黄免疫球蛋白的方法
JP6967308B1 (ja)	2020-06-30	2021-11-17	国立大学法人高知大学	胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN113755432B (zh) *	2020-07-17	2022-06-10	上海我武干细胞科技有限公司	干细胞培养方法
WO2022046954A1 (en) *	2020-08-25	2022-03-03	Celularity Inc.	Appl cells improved placental-derived adherent cells and methods of their use
CN114246985A (zh) *	2020-09-25	2022-03-29	华东理工大学	一种类骨膜组织的仿生构建方法
US12347100B2 (en)	2020-11-19	2025-07-01	Mazor Robotics Ltd.	Systems and methods for generating virtual images
EP4259053B1 (en)	2020-12-22	2026-04-08	Genentech, Inc.	Ocular cannula guide
JP7785378B2 (ja) *	2021-01-12	2025-12-15	セラトズセラピュティクスインコーポレイテッド	神経再生活性を有する神経再生促進細胞のスクリーニング方法
CN116802501A (zh) *	2021-01-12	2023-09-22	雪拉托兹治疗株式会社	具有神经元再生活性的神经元再生促进细胞的筛选方法
GB2619893A (en)	2021-03-23	2023-12-20	Terumo Bct Inc	Cell capture and expansion
US20250049981A1 (en) *	2021-12-17	2025-02-13	Solventum Intellectual Properties Company	Wound Dressings and Methods of Making the Same
US12435312B2 (en)	2022-02-28	2025-10-07	Brown University	Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model
US12152699B2 (en)	2022-02-28	2024-11-26	Terumo Bct, Inc.	Multiple-tube pinch valve assembly
CN115068438B (zh) *	2022-04-28	2023-09-22	浙江大学医学院附属邵逸夫医院	破骨细胞前体同源靶向的细胞膜纳米囊泡制备方法及应用
ES2956802B2 (es) *	2022-05-20	2025-10-02	Bioiberica S A U	Hidrogeles para su uso en ingenieria de tejidos de la piel
CN115044542B (zh) *	2022-06-30	2023-09-26	上海市东方医院（同济大学附属东方医院）	Sj000291942在诱导间充质干细胞成骨分化方面的应用
WO2024024708A1 (ja) *	2022-07-26	2024-02-01	国立大学法人大阪大学	軟骨修復用組成物及びその製造方法
USD1099116S1 (en)	2022-09-01	2025-10-21	Terumo Bct, Inc.	Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
WO2024052733A1 (en)	2022-09-06	2024-03-14	Gyroscope Therapeutics Limited	Apparatus for subretinal administration of therapeutic agent via dual-curved needle
WO2024116114A1 (en)	2022-11-30	2024-06-06	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
EP4379046A1 (en)	2022-11-30	2024-06-05	Universidade Nova De Lisboa	A 3d cellular model of early diabetic retinopathy
CN116218769B (zh) *	2023-01-03	2025-09-05	深圳市汉科生物工程有限公司	一种促进软骨细胞生长的方法
EP4648726A2 (en)	2023-01-13	2025-11-19	Genentech, Inc.	Dose dock for syringe
WO2024172859A1 (en) *	2023-02-17	2024-08-22	Spine Biopharma, Inc.	Peptide formulations
TW202529711A (zh)	2023-09-29	2025-08-01	美商建南德克公司	眼插管導引器、施用器及標記器械
WO2025080727A1 (en) *	2023-10-10	2025-04-17	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Autologous serum insert for treating an ocular condition
TW202602405A (zh)	2024-03-27	2026-01-16	美商建南德克公司	用於視網膜下注射裝置的扭矩環
US12502407B2 (en)	2024-04-25	2025-12-23	Direct Biologics, Llc	Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (326)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US229971A (en)		1880-07-13		Ttornets
US2324800A (en)	1941-08-14	1943-07-20	Pfizer Charles & Co	Purification of riboflavin
US2654735A (en) *	1949-07-29	1953-10-06	Us Vitamin Corp	Process for the production of derivatives of 9-polyhydroxyalkylisoalloxazines and products obtained
US2864848A (en)	1954-07-19	1958-12-16	Ca Nat Research Council	Method of producing l-alpha-glycerylphosphorylcholine
US2912332A (en) *	1958-02-27	1959-11-10	Swift & Co	Stabilized thiamine composition and method of enriching food products
US3665061A (en)	1969-07-16	1972-05-23	United States Banknote Corp	Process for producing collagen sponges
JPS5651747B2 (pl)	1973-05-31	1981-12-08
CH635748A5 (fr)	1977-08-16	1983-04-29	Cellorgan Laboratoires Sa	Procede d'obtention de cellules placentaires de brebis.
US4216144A (en)	1977-10-20	1980-08-05	Ashmead H H	Soluble iron proteinates
JPS6040439B2 (ja)	1978-03-29	1985-09-11	大正製薬株式会社	ヒドロコルチゾン誘導体
US4352883A (en)	1979-03-28	1982-10-05	Damon Corporation	Encapsulation of biological material
US4393240A (en)	1981-07-06	1983-07-12	Stille John K	Optically active phosphines
US4544516A (en)	1982-07-28	1985-10-01	Battelle Development Corporation	Collagen orientation
US4465776A (en)	1982-09-27	1984-08-14	Research Corporation	Monoclonal antibodies to vitamin B6 and immunoassay method
US4657866A (en)	1982-12-21	1987-04-14	Sudhir Kumar	Serum-free, synthetic, completely chemically defined tissue culture media
US4487865A (en)	1983-12-15	1984-12-11	Biomatrix, Inc.	Polymeric articles modified with hyaluronate
US5266480A (en)	1986-04-18	1993-11-30	Advanced Tissue Sciences, Inc.	Three-dimensional skin culture system
US5863531A (en)	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4963489A (en)	1987-04-14	1990-10-16	Marrow-Tech, Inc.	Three-dimensional cell and tissue culture system
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US4925667A (en)	1986-05-27	1990-05-15	Qmax Technology Group, Inc.	Substrate with particulate cosmetic
JPS642643A (en)	1987-06-26	1989-01-06	Bio Material Yunibaasu:Kk	Artificial skin
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5004681B1 (en)	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5162405A (en) *	1987-12-24	1992-11-10	Elf Atochem North America, Inc.	Single-functional and mixtures of multi-functional oligomeric performance additive compositions and their uses
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US4963439A (en)	1988-04-19	1990-10-16	Ube Industries, Ltd.	Continuous fiber-reinforced Al-Co alloy matrix composite
US20030032178A1 (en)	1988-08-04	2003-02-13	Williams Robert Lindsay	In vitro propagation of embryonic stem cells
US5618670A (en) *	1988-08-26	1997-04-08	The United States Of America As Represented By The Department Of Health & Human Services	Detection method for c-raf-1 genes
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5284766A (en) *	1989-02-10	1994-02-08	Kao Corporation	Bed material for cell culture
JPH06104061B2 (ja)	1989-02-10	1994-12-21	花王株式会社	細胞培養支持体材料
DE69009237T2 (de) *	1989-02-27	1994-12-01	Takasago Perfumery Co Ltd	Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5437994A (en) *	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5574205A (en)	1989-07-25	1996-11-12	Cell Genesys	Homologous recombination for universal donor cells and chimeric mammalian hosts
US5840580A (en)	1990-05-01	1998-11-24	Becton Dickinson And Company	Phenotypic characterization of the hematopoietic stem cell
US5145770A (en) *	1990-06-04	1992-09-08	Biosurface Technology, Inc.	Cryopreservation of cultured epithelial sheets
ATE352612T1 (de)	1990-08-29	2007-02-15	Pharming Intellectual Pty Bv	Homologe rekombination in säugetier-zellen
US5336616A (en) *	1990-09-12	1994-08-09	Lifecell Corporation	Method for processing and preserving collagen-based tissues for transplantation
US5342761A (en)	1990-10-01	1994-08-30	Research Development Foundation	Oncofetal gene, gene product and uses therefor
US5506134A (en)	1990-10-22	1996-04-09	Corvas International, Inc.	Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
US5811094A (en) *	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5140100A (en) *	1990-12-28	1992-08-18	Cedars-Sinai Medical Center	Protein that inhibits production of human choriogonadotropin
US5286632A (en)	1991-01-09	1994-02-15	Jones Douglas H	Method for in vivo recombination and mutagenesis
NL9100038A (nl)	1991-01-11	1992-08-03	Stamicarbon	Enzym-gekatalyseerde bereiding van optisch aktieve carbonzuren.
SK120193A3 (en)	1991-05-02	1994-07-06	Yeda Res & Dev	Pharmaceutical composition for the prevention and/or treatment of pathological processes
US6399369B1 (en)	1991-07-08	2002-06-04	Neurospheres Holdings Ltd.	Multipotent neural stem cell cDNA libraries
EP0552380A4 (en)	1991-08-08	1995-01-25	Kao Corp	Cell culture support, production thereof, and production of cell cluster using same
EP0529751A1 (en)	1991-08-09	1993-03-03	W.R. Grace & Co.-Conn.	Cell culture substrate, test material for cell culture and preparations thereof
WO1993004169A1 (en)	1991-08-20	1993-03-04	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
WO1993006726A1 (en) *	1991-09-30	1993-04-15	Mackenzie Walser	Methods for treatment of free-radical-mediated tissue injury
US5308763A (en) *	1991-10-01	1994-05-03	The Johns Hopkins University	Method of making primary culture of olfactory neurons
US5914265A (en) *	1992-04-30	1999-06-22	Baylor College Of Medicine	Keratin K1 expression vectors and methods of use
WO1994000484A1 (en)	1992-06-22	1994-01-06	Young Henry E	Scar inhibitory factor and use thereof
US5320962A (en)	1992-07-22	1994-06-14	Duke University	DNA encoding the human A1 adenosine receptor
US5589376A (en)	1992-07-27	1996-12-31	California Institute Of Technology	Mammalian neural crest stem cells
US5356807A (en) *	1992-09-08	1994-10-18	Cornell Research Foundation	Cultured cell line of adult diploid cells from human brain and meningeal tissue
US20040224409A1 (en)	1992-09-25	2004-11-11	Laurent Pradier	Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
JP3490443B2 (ja)	1992-10-29	2004-01-26	ジ・オーストラリアン・ナショナル・ユニバーシティ	血管形成阻害性抗体
US5670483A (en)	1992-12-28	1997-09-23	Massachusetts Insititute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en)	1992-12-28	1999-09-21	Massachusetts Institute Of Technology	Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5707643A (en)	1993-02-26	1998-01-13	Santen Pharmaceutical Co., Ltd.	Biodegradable scleral plug
WO1994022451A1 (en) *	1993-04-07	1994-10-13	Oklahoma Medical Research Foundation	Selective regulation of b lymphocyte precursors by hormones
WO1994025584A1 (en)	1993-04-28	1994-11-10	Johns Hopkins University School Of Medicine	Chronic endothelial cell culture under flow
IL110589A0 (en)	1993-08-10	1994-11-11	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF- beta family
JP3680114B2 (ja)	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
US6686198B1 (en)	1993-10-14	2004-02-03	President And Fellows Of Harvard College	Method of inducing and maintaining neuronal cells
US6432711B1 (en)	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
US5456835A (en) *	1993-11-08	1995-10-10	Hemasure, Inc.	Device and process for removing free hemoglobin from blood
DE4406073A1 (de) *	1994-02-24	1995-08-31	Univ Ludwigs Albert	Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten
US5698518A (en)	1994-03-30	1997-12-16	Oklahoma Medical Research Foundation	Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5466233A (en)	1994-04-25	1995-11-14	Escalon Ophthalmics, Inc.	Tack for intraocular drug delivery and method for inserting and removing same
US6001647A (en)	1994-04-28	1999-12-14	Ixion Biotechnology, Inc.	In vitro growth of functional islets of Langerhans and in vivo uses thereof
US6703017B1 (en)	1994-04-28	2004-03-09	Ixion Biotechnology, Inc.	Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US5834308A (en)	1994-04-28	1998-11-10	University Of Florida Research Foundation, Inc.	In vitro growth of functional islets of Langerhans
CA2192103C (en)	1994-06-06	2002-02-05	Arnold I. Caplan	Biomatrix for tissue regeneration
IL114397A0 (en)	1994-07-01	1995-10-31	Bioph Biotech Entw Pharm Gmbh	Growth/differentiation factor of the TGF-beta-family
US5935849A (en) *	1994-07-20	1999-08-10	Cytotherapeutics, Inc.	Methods and compositions of growth control for cells encapsulated within bioartificial organs
US6309853B1 (en)	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5660982A (en) *	1994-10-04	1997-08-26	Tryggvason; Karl	Laminin chains: diagnostic uses
US5789147A (en)	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5725493A (en)	1994-12-12	1998-03-10	Avery; Robert Logan	Intravitreal medicine delivery
US5684032A (en)	1994-12-13	1997-11-04	Smithkline Beecham Corporation	Compounds
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en)	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5718922A (en)	1995-05-31	1998-02-17	Schepens Eye Research Institute, Inc.	Intravitreal microsphere drug delivery and method of preparation
US5869079A (en)	1995-06-02	1999-02-09	Oculex Pharmaceuticals, Inc.	Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5693332C1 (en)	1995-08-11	2001-01-09	Univ California	Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5641750A (en) *	1995-11-29	1997-06-24	Amgen Inc.	Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6200606B1 (en) *	1996-01-16	2001-03-13	Depuy Orthopaedics, Inc.	Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en)	1996-02-21	1998-12-01	Advanced Tissue Sciences, Inc.	Method for repairing cartilage
DK0888452T3 (da)	1996-03-15	2004-06-14	Munin Corp	Human CYR61, et ekstracellulært matrix-signalmolekyle
US6223188B1 (en) *	1996-04-10	2001-04-24	Sun Microsystems, Inc.	Presentation of link information as an aid to hypermedia navigation
AU2808397A (en)	1996-04-26	1997-11-19	Case Western Reserve University	Skin regeneration using mesenchymal stem cells
US6358737B1 (en) *	1996-07-31	2002-03-19	Board Of Regents, The University Of Texas System	Osteocyte cell lines
US6787355B1 (en)	1996-08-26	2004-09-07	Mcgill University	Multipotent neural stem cells from peripheral tissues and uses thereof
US5919702A (en)	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
AU6242298A (en) *	1997-01-17	1998-08-07	Celadon Science, Llc	Methods for promoting healing of corneal resurfacing wounds
WO1998033515A1 (en)	1997-02-05	1998-08-06	Case Western Reserve University	STIMULATORY EFFECTS OF bFGF AND BMP-2 ON OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
AU7481098A (en)	1997-05-13	1998-12-08	Case Western Reserve University	Osteoarthritis cartilage regeneration using human mesenchymal stem ce lls
EP0983062A4 (en)	1997-05-21	2002-10-23	Sloan Kettering Inst Cancer	METHOD FOR INCREASING THE CONCENTRATION OF ASCOBIC ACID IN PERSONAL BRAIN TISSUE
JP4132089B2 (ja)	1997-05-30	2008-08-13	オステオバイオロジックス，インコーポレイテッド	繊維強化多孔性生体分解性移植デバイス
CA2296704C (en)	1997-07-14	2010-10-19	Osiris Therapeutics, Inc.	Cardiac muscle regeneration using mesenchymal stem cells
US5902598A (en)	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
CA2312847C (en)	1997-12-02	2014-09-30	Zen Bio, Inc.	Differentiation of adipose stromal cells into osteoblasts and uses thereof
US6059968A (en)	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
US6291240B1 (en)	1998-01-29	2001-09-18	Advanced Tissue Sciences, Inc.	Cells or tissues with increased protein factors and methods of making and using same
AU749675B2 (en)	1998-03-13	2002-07-04	Mesoblast International Sarl	Uses for human non-autologous mesenchymal stem cells
CN1297354A (zh)	1998-03-16	2001-05-30	西托维亚公司	二肽卡斯帕酶抑制剂及其用途
US6179872B1 (en)	1998-03-17	2001-01-30	Tissue Engineering	Biopolymer matt for use in tissue repair and reconstruction
US6171610B1 (en)	1998-04-24	2001-01-09	University Of Massachusetts	Guided development and support of hydrogel-cell compositions
WO1999056759A1 (en)	1998-05-07	1999-11-11	University Of South Florida	Bone marrow cells as a source of neurons for brain and spinal cord repair
PT1082410E (pt)	1998-05-29	2007-11-09	Osiris Therapeutics Inc	Células estaminais mesenquimatosas humanas cd45+ e/ou fibroblastos+
US6323188B1 (en)	1998-07-01	2001-11-27	Donald L. Weissman	Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
DE19833340A1 (de)	1998-07-24	2000-02-10	Karlsruhe Forschzent	Wurmförmiger Arbeitsmechanismus
US20040037818A1 (en)	1998-07-30	2004-02-26	Brand Stephen J.	Treatment for diabetes
ATE445006T1 (de)	1998-08-10	2009-10-15	Us Gov Health & Human Serv	Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
US6284245B1 (en)	1998-08-25	2001-09-04	Diacrin, Inc.	Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
US6444205B2 (en)	1998-09-30	2002-09-03	Diacrin, Inc.	Transplantation of neural cells for the treatment of chronic pain or spasticity
US6610540B1 (en) *	1998-11-18	2003-08-26	California Institute Of Technology	Low oxygen culturing of central nervous system progenitor cells
US6241369B1 (en) *	1998-11-20	2001-06-05	Cooper Technologies Company	Quick mount fixture
US6144054A (en) *	1998-12-04	2000-11-07	International Business Machines Corporation	DRAM cell having an annular signal transfer region
DE19856428C1 (de) *	1998-12-08	2000-05-04	Heraeus Noblelight Gmbh	Entladungslampe
HK1041454B (en)	1998-12-24	2004-12-31	生物安全股份有限公司	Blood separation system particularly for concentrating hematopoietic stem cells
JP4932069B2 (ja)	1999-01-25	2012-05-16	株式会社セルシード	アクリルアミド誘導体および該誘導体を含む重合体
CA2359821A1 (en)	1999-02-04	2000-08-10	Mcgill University	Platform for the differentiation of cells
JP2002538779A (ja)	1999-02-10	2002-11-19	キュリスインコーポレイテッド	膵臓細胞前駆細胞、それらに関する方法及び利用
US6592623B1 (en) *	1999-08-31	2003-07-15	Virginia Commonwealth University Intellectual Property Foundation	Engineered muscle
BR0008552A (pt)	1999-03-10	2002-05-07	Univ Pittsburgh	Células tronco e redes derivadas de tecido adiposo
US20030007954A1 (en)	1999-04-12	2003-01-09	Gail K. Naughton	Methods for using a three-dimensional stromal tissue to promote angiogenesis
JP2002542349A (ja)	1999-04-16	2002-12-10	ダブリューエム・マーシュ・ライス・ユニバーシティー	ポリ（プロピレンフマラート）−ジアクリレートマクロマーで交差結合された生体分解性のポリ（プロピレンフマラート）ネットワーク
US6261600B1 (en)	1999-04-30	2001-07-17	Drugtech Corporation	Folic acid supplement
US6372494B1 (en)	1999-05-14	2002-04-16	Advanced Tissue Sciences, Inc.	Methods of making conditioned cell culture medium compositions
US6287340B1 (en)	1999-05-14	2001-09-11	Trustees Of Tufts College	Bioengineered anterior cruciate ligament
AU4860900A (en)	1999-06-02	2000-12-18	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US6329904B1 (en) *	1999-06-11	2001-12-11	Safety Through Cellular, Inc.	Apparatus and method for providing weather and other alerts
AU5886000A (en)	1999-06-25	2001-01-31	Northwestern University	Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
US6333029B1 (en)	1999-06-30	2001-12-25	Ethicon, Inc.	Porous tissue scaffoldings for the repair of regeneration of tissue
US6355699B1 (en)	1999-06-30	2002-03-12	Ethicon, Inc.	Process for manufacturing biomedical foams
EP2348104A1 (en)	1999-08-05	2011-07-27	Mcl Llc	Multipotent adult stem cells and methods for isolation
US7838289B2 (en)	2001-02-14	2010-11-23	Abt Holding Company	Assay utilizing multipotent adult stem cells
US6429013B1 (en)	1999-08-19	2002-08-06	Artecel Science, Inc.	Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en)	1999-08-19	2003-04-29	Artecel Sciences, Inc.	Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
AU7378600A (en)	1999-09-14	2001-04-17	Children's Medical Center Corporation	Methods for treating muscular dystrophy
US6331313B1 (en)	1999-10-22	2001-12-18	Oculex Pharmaceticals, Inc.	Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030129745A1 (en)	1999-10-28	2003-07-10	Robl James M.	Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
EP1099754A1 (en)	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
US20030082155A1 (en)	1999-12-06	2003-05-01	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20020164307A1 (en)	1999-12-06	2002-11-07	Habener Joel F.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20010046489A1 (en)	1999-12-06	2001-11-29	Habener Joel E.	Stem cells of the islets of langerhans and their use in treating diabetes mellitus
WO2001053503A1 (en)	2000-01-18	2001-07-26	Cornell Research Foundation, Inc.	Neural progenitor cells from hippocampal tissue and a method for isolating and purifying them
US7544509B2 (en)	2000-01-24	2009-06-09	Mcgill University	Method for preparing stem cell preparations
US6610535B1 (en)	2000-02-10	2003-08-26	Es Cell International Pte Ltd.	Progenitor cells and methods and uses related thereto
ES2292564T3 (es)	2000-02-11	2008-03-16	Philadelphia Health And Education Corporation	Diferenciacion de celulas de la medula osea en celulas neuronales y usos asociados.
AU3499801A (en)	2000-02-11	2001-08-20	Schepens Eye Res Inst	Isolation and transplantation of retinal stem cells
EP1263930A4 (en)	2000-03-09	2004-07-21	Saneron Ccel Therapeutics Inc	HUMAN CORD BLOOD BLOOD AS A SOURCE FOR NEURAL TISSUE FOR HEALING THE BRAIN AND BACK MARK
WO2001065934A2 (en) *	2000-03-09	2001-09-13	Lee Walters	Applications of immune system tolerance to treatment of various diseases
EP1264877B1 (en)	2000-03-16	2013-10-02	Cellseed Inc.	Cell cultivation-support material, method of cocultivation of cells and cocultivated cell sheet obtained therefrom
US6436704B1 (en)	2000-04-10	2002-08-20	Raven Biotechnologies, Inc.	Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6673606B1 (en)	2000-04-12	2004-01-06	The Children's Hospital Of Philadelphia	Therapeutic uses for mesenchymal stromal cells
US6375972B1 (en) *	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
CA2408701A1 (en)	2000-05-12	2001-11-22	University Of Utah Research Foundation	Compositions and methods for tissue dedifferentiation and regeneration
US8273570B2 (en)	2000-05-16	2012-09-25	Riken	Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
US7049072B2 (en)	2000-06-05	2006-05-23	University Of South Florida	Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
US6759039B2 (en)	2000-06-30	2004-07-06	Amcyte, Inc.	Culturing pancreatic stem cells having a specified, intermediate stage of development
EP2264148A1 (en)	2000-07-21	2010-12-22	Cellseed Inc.	Epidermal cultured cell sheet, multi-layered cultured skin sheet and processes for producing those sheets
DE60143892D1 (de)	2000-07-21	2011-03-03	Cellseed Ind	Herzmuskel-ähnliche zellschicht, dreidimensionales konstrukt, herzmuskel-ähnliches gewebe und verfahren zur herstellung
US6984522B2 (en)	2000-08-03	2006-01-10	Regents Of The University Of Michigan	Isolation and use of solid tumor stem cells
DE10038814A1 (de) *	2000-08-09	2002-02-21	Abb Research Ltd	Hochspannungs-Gleichstromwandler
CA2424062A1 (en)	2000-09-29	2002-04-04	Derek Van Der Kooy	Primitive neural stem cells and method for differentiation of stem cells to neural cells
US6639470B1 (en)	2000-10-06	2003-10-28	Skyworks Solutions, Inc.	Constant current biasing circuit for linear power amplifiers
US7560280B2 (en)	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
AU2002230669A1 (en)	2000-11-06	2002-05-15	The Salk Institute For Biological Studies	Postmortem stem cells
AU2001297880B2 (en)	2000-11-30	2007-05-31	Stemron Inc.	Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2305795B1 (en)	2000-12-06	2019-07-03	Celularity, Inc.	Method of collecting placental stem cells
US6599323B2 (en)	2000-12-21	2003-07-29	Ethicon, Inc.	Reinforced tissue implants and methods of manufacture and use
CA2365376C (en)	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
AU2002239810A1 (en)	2001-01-02	2002-07-16	The Charles Stark Draper Laboratory, Inc.	Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
CA2435826A1 (en)	2001-01-24	2002-08-01	The Government Of The United States Of America	Differentiation of stem cells to pancreatic endocrine cells
WO2002061053A1 (en)	2001-01-31	2002-08-08	The General Hospital Corporation	Renal stem cells and uses thereof
EP1367961B1 (en)	2001-02-06	2008-12-31	Massachusetts Institute Of Technology	Peptide scaffold encapsulation of tissue cells and uses thereof
US7449180B2 (en)	2001-02-06	2008-11-11	John Kisiday	Macroscopic scaffold containing amphiphilic peptides encapsulating cells
ES2432493T3 (es)	2001-02-14	2013-12-03	Anthrogenesis Corporation	Placenta de mamífero post-parto, su uso y células madre de la misma
EP2316918B1 (en) *	2001-02-14	2015-07-01	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
WO2002077199A2 (en) *	2001-03-27	2002-10-03	Massachusetts Institute Of Technology	Methods and products related to fgf dimerization
EP1385935A4 (en)	2001-03-29	2004-09-15	Ixion Biotechnology Inc	METHOD FOR TRANSDIFFERENTIATION OF NON-PANCREATIC STEM CELLS IN THE PANCREAS DIFFERENTIATION PATHWAY
US7838292B1 (en)	2001-03-29	2010-11-23	University Of Louisville Research Foundation, Inc.	Methods for obtaining adult human olfactory progenitor cells
US20050054102A1 (en)	2001-04-19	2005-03-10	Anna Wobus	Method for differentiating stem cells into insulin-producing cells
KR100762261B1 (ko)	2001-04-27	2007-10-04	(주)바이오니아	전장 상보 디옥시리보핵산 제조 방법과 이에 사용되는앵커와 프라이머
US20030211605A1 (en)	2001-05-01	2003-11-13	Lee Sang-Hun	Derivation of midbrain dopaminergic neurons from embryonic stem cells
US20030022369A1 (en)	2001-05-18	2003-01-30	Helen Fillmore	Differentiation of specialized dermal and epidermal cells into neuronal cells
EP1401282A4 (en)	2001-05-25	2005-03-30	Cythera Inc	DIFFERENTIATION OF STEM CELLS
EP1406573A4 (en)	2001-06-07	2005-03-30	Skinmedica Inc	CONDITIONED CELL CULTURE MEDIA AND ITS USES
RU2183966C1 (ru)	2001-07-06	2002-06-27	Общество с ограниченной ответственностью "Сибларекс"	Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий
US6402263B1 (en)	2001-07-24	2002-06-11	Robert Bosch Corporation	Dual actuation master cylinder
AU2002324645C1 (en)	2001-08-08	2008-11-06	Levesque Biosciences, Inc.	Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
US20030211603A1 (en)	2001-08-14	2003-11-13	Earp David J.	Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
AU2002313817A1 (en)	2001-08-27	2003-03-10	Advanced Cell Technology, Inc.	Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US20030104997A1 (en)	2001-09-05	2003-06-05	Black Ira B.	Multi-lineage directed induction of bone marrow stromal cell differentiation
CN1195055C (zh)	2001-09-06	2005-03-30	周胜利	从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
US20050064587A1 (en)	2001-09-07	2005-03-24	Lawrence Rosenberg	Pancreatic small cells and uses thereof
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US7072332B2 (en) *	2001-09-27	2006-07-04	Samsung Electronics Co., Ltd.	Soft switch using distributed firewalls for load sharing voice-over-IP traffic in an IP network
EP1298201A1 (en)	2001-09-27	2003-04-02	Cardion AG	Process for the production of cells exhibiting an islet-beta-cell-like state
WO2003029443A1 (en)	2001-09-28	2003-04-10	Es Cell International Pte Ltd	Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers
CA2463914A1 (en)	2001-10-18	2003-04-24	Ixion Biotechnology, Inc.	Conversion of liver stem and progenitor cells to pancreatic functional cells
US7129034B2 (en) *	2001-10-25	2006-10-31	Cedars-Sinai Medical Center	Differentiation of whole bone marrow
KR20050044393A (ko)	2001-11-09	2005-05-12	아르테셀 사이언스, 인크.	지방 조직 유래된 스트로마 세포의 내분비 췌장 분화 및이의 용도
US7491690B2 (en)	2001-11-14	2009-02-17	Northwestern University	Self-assembly and mineralization of peptide-amphiphile nanofibers
JP4330995B2 (ja)	2001-11-15	2009-09-16	チルドレンズメディカルセンターコーポレーション	絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法
JP3728750B2 (ja)	2001-11-22	2005-12-21	ニプロ株式会社	培養皮膚及びその製造方法
CN1596130A (zh)	2001-11-28	2005-03-16	安琪士多摩奇株式会社	治疗神经退行性疾病的基因治疗药物
US6712850B2 (en)	2001-11-30	2004-03-30	Ethicon, Inc.	Porous tissue scaffolds for the repair and regeneration of dermal tissue
ATE532854T1 (de)	2001-12-04	2011-11-15	Organogenesis Inc	Kultivierte zellen aus den langerhansschen inseln
WO2003047607A1 (fr) *	2001-12-06	2003-06-12	Sankyo Company, Limited	Compositions medicales contenant des cellules amniotiques humaines
AU2002341725A1 (en)	2001-12-06	2003-07-09	The Regents Of The University Of California	Method for differentiating islet precursor cells into beta cells
CA2470539C (en) *	2001-12-07	2011-10-04	Geron Corporation	Islet cells from human embryonic stem cells
US7504258B2 (en) *	2001-12-11	2009-03-17	Cytograft Tissue Engineering, Inc.	Tissue engineered cellular sheets, methods of making and use thereof
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
US20030113910A1 (en)	2001-12-18	2003-06-19	Mike Levanduski	Pluripotent stem cells derived without the use of embryos or fetal tissue
EP1458854B1 (en)	2001-12-21	2010-04-14	Mount Sinai Hospital	Cellular compositions and methods of making and using them
US7101546B2 (en)	2001-12-21	2006-09-05	Amcyte, Inc.	In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
CN1671835A (zh)	2001-12-28	2005-09-21	塞拉提斯股份公司	一种建立多能人胚泡衍生的干细胞的方法
EP1471970A4 (en)	2002-01-14	2006-08-02	Univ Illinois	NOVEL MULTIPOTENT STEM CELLS OF MAMMALIAN ORIGIN, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION OF SAID CELLS
US20030158089A1 (en)	2002-01-24	2003-08-21	Xenoport, Inc.	Administrative agents via the SMVT transporter
US20030162290A1 (en)	2002-01-25	2003-08-28	Kazutomo Inoue	Method for inducing differentiation of embryonic stem cells into functioning cells
WO2003066832A2 (en)	2002-02-07	2003-08-14	The Research Foundation Of The State University Of New York	Generation of new insulin cells from progenitor cells present in adult pancreatic islets
NZ534643A (en) *	2002-02-13	2010-06-25	Anthrogenesis Corp	Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
WO2003070189A2 (en)	2002-02-15	2003-08-28	Cornell Research Foundation, Inc.	Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
AU2003215280A1 (en)	2002-02-15	2003-09-09	Northwestern University	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
EP1483371B1 (en)	2002-02-19	2007-06-27	Medipost, Co., Ltd.	Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
WO2003072728A2 (en)	2002-02-22	2003-09-04	University Of Florida	Cellular trans-differentiation
US7736892B2 (en) *	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) *	2002-02-25	2003-08-28	Kansas State University Research Foundation	Cultures, products and methods using stem cells
US7150990B2 (en)	2002-03-06	2006-12-19	Reprocell, Inc.	Self-renewing pluripotent hepatic stem cells
JP2003259862A (ja)	2002-03-12	2003-09-16	Fuji Photo Film Co Ltd	細胞培養担体
AU2003221173A1 (en)	2002-03-27	2003-10-08	Asahi Kasei Kabushiki Kaisha	Placenta-origin mesenchymal cells and medicinal use thereof
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
KR20050000400A (ko)	2002-04-12	2005-01-03	셀진 코포레이션	줄기 및 전구 세포 분화의 조절, 측정 및 이들의 용도
JP4136434B2 (ja)	2002-04-17	2008-08-20	進清野	インスリン産生細胞の誘導
US20030235563A1 (en)	2002-04-19	2003-12-25	Strom Stephen C.	Placental derived stem cells and uses thereof
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
WO2003090689A2 (en)	2002-04-25	2003-11-06	Wisconsin Alumni Research Foundation	Neurodegenerative disorder treatment using gdnf secreting neural cells
US20040029269A1 (en)	2002-05-07	2004-02-12	Goldman Steven A	Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
WO2003094965A2 (en)	2002-05-08	2003-11-20	Neuronova Ab	Modulation of neural stem cells with s1p or lpa receptor agonists
WO2003102134A2 (en)	2002-05-28	2003-12-11	Becton, Dickinson And Company	Pancreatic acinar cells into insulin producing cells
CA2488013A1 (en)	2002-05-30	2003-12-11	Celgene Corporation	Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
CA2488425A1 (en)	2002-06-07	2003-12-18	Es Cell International Pte Ltd	Methods of regulating differentiation in stem cells
AU2003247514A1 (en)	2002-06-11	2003-12-22	Roy Ogle	Meningeal-derived stem cells
WO2004003561A1 (en)	2002-06-27	2004-01-08	Northwestern University	Peptide rod amphiphiles and self-assembly of same
US7285415B2 (en)	2002-07-11	2007-10-23	The Regents Of The University Of California	Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
GB0216286D0 (en)	2002-07-15	2002-08-21	Univ Leeds	Network
EP1551955A4 (en) *	2002-07-16	2006-11-29	Yissum Res Dev Co	METHOD FOR IMPLANTING MESENCHYMAL STEM CELLS FOR TISSUE PAIRING AND FORMATION
US7390659B2 (en)	2002-07-16	2008-06-24	The Trustees Of Columbia University In The City Of New York	Methods for inducing differentiation of embryonic stem cells and uses thereof
JP2005534345A (ja)	2002-07-29	2005-11-17	エスセルインターナショナルピーティーイーリミテッド	インスリン陽性、グルコース応答性細胞の分化のための多段階方法
AU2003250666A1 (en)	2002-07-29	2004-02-16	Asahi Kasei Kabushiki Kaisha	Stem cells for treating pancreatic damage
WO2004016747A2 (en)	2002-08-14	2004-02-26	University Of Florida	Bone marrow cell differentiation
AU2003265094A1 (en)	2002-08-26	2004-03-11	Neuronova Ab	Method for culturing stem cells
US20040063202A1 (en)	2002-08-28	2004-04-01	Petersen Bryon E.	Neurogenesis from hepatic stem cells
AU2003268534A1 (en)	2002-09-06	2004-03-29	Amcyte Inc.	Cd56 positive human adult pancreatic endocrine progenitor cells
US6766863B2 (en) *	2002-09-20	2004-07-27	Hypro Corporation	Fire fighting foam injection system with auto-start feature
US9969977B2 (en)	2002-09-20	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US20040062753A1 (en)	2002-09-27	2004-04-01	Alireza Rezania	Composite scaffolds seeded with mammalian cells
JP4262465B2 (ja) *	2002-10-24	2009-05-13	富士フイルム株式会社	細胞培養方法
AU2003287444A1 (en)	2002-10-31	2004-05-25	The General Hospital Corporation	Repairing or replacing tissues or organs
WO2004052177A2 (en)	2002-12-05	2004-06-24	Case Western Reserve University	Cell-based therapies for ischemia
JP4571387B2 (ja)	2003-02-07	2010-10-27	宣男櫻川	ヒト羊膜由来サイドポピュレーション細胞及びその用途
EP2277992A3 (en) *	2003-02-11	2011-03-02	John E. Davies	Progenitor cells from Wharton's jelly of human umbilical cord
WO2004072104A2 (en)	2003-02-11	2004-08-26	Northwestern University	Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
US7521481B2 (en) *	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
US20040224401A1 (en) *	2003-03-28	2004-11-11	Ludwig Tenneille E.	Physiochemical culture conditions for embryonic stem cells
US7960166B2 (en)	2003-05-21	2011-06-14	The General Hospital Corporation	Microfabricated compositions and processes for engineering tissues containing multiple cell types
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
EP2399990B1 (en)	2003-06-27	2015-07-22	DePuy Synthes Products, Inc.	Cells derived from post-partum umbilical cord for use in treatment of disease of the heart and circulatory system
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
AU2004269409A1 (en)	2003-08-29	2005-03-10	Regents Of The University Of Minnesota	Kidney derived stem cells and methods for their isolation, differentiation and use
US20050089513A1 (en) *	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
NZ547829A (en)	2003-12-23	2009-04-30	Fmc Biopolymer As	Use of alginate matrices to control cell growth
TWI276685B (en)	2003-12-30	2007-03-21	Ind Tech Res Inst	Conditional medium for culturing Schwann cells
US7534606B2 (en)	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
DE102004043256B4 (de)	2004-09-07	2013-09-19	Rheinische Friedrich-Wilhelms-Universität Bonn	Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension
US8039258B2 (en)	2004-09-28	2011-10-18	Ethicon, Inc.	Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
EP1812557A4 (en)	2004-10-29	2009-11-04	Centocor Ortho Biotech Inc	COMPOSITIONS OF CHEMICALLY DEFINED MEDIA
US7655678B2 (en) *	2004-11-30	2010-02-02	Council of Scientfic & Industrial Research	Pharmaceutical composition for the management of tumors
US20060171930A1 (en)	2004-12-21	2006-08-03	Agnieszka Seyda	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US20060166361A1 (en)	2004-12-21	2006-07-27	Agnieszka Seyda	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060153815A1 (en)	2004-12-21	2006-07-13	Agnieszka Seyda	Tissue engineering devices for the repair and regeneration of tissue
CA2589041C (en)	2004-12-23	2019-08-20	DePuy Synthes Products, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
EP1831355A2 (en)	2004-12-23	2007-09-12	Ethicon, Inc.	Soft tissue repair and regeneration using postpartum-derived cells and cell products
EP1835924B1 (en)	2004-12-23	2013-08-21	Ethicon, Incorporated	Treatment of parkinson's disease and related disorders using postpartum derived cells
EP1838842A2 (en)	2004-12-23	2007-10-03	Ethicon, Incorporated	Treatment of osteochondral diseases using postpartum-derived cells and products thereof
US7741311B2 (en)	2005-01-03	2010-06-22	Shaker Mousa	Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
CA2596231A1 (en)	2005-01-28	2006-08-03	Novathera Ltd	Methods for embryonic stem cell culture
CN103361301A (zh)	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	高度纯化来自羊膜的细胞群
US7923007B2 (en)	2005-08-08	2011-04-12	Academia Sinica	Brain tissue damage therapies
WO2007070870A1 (en)	2005-12-16	2007-06-21	Ethicon, Inc.	Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US8741638B2 (en)	2005-12-19	2014-06-03	DePuy Synthes Products, LLC	In vitro expansion of postpartum-derived cells in roller bottles
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
EP1979050B1 (en)	2005-12-28	2017-04-19	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using postpartum-derived cells
PL2471907T3 (pl)	2005-12-29	2019-07-31	Celularity, Inc.	Populacje komórek macierzystych łożyska
EP1989318B1 (en)	2006-01-06	2014-07-30	Agilent Technologies, Inc.	Reaction buffer composition for nucleic acid replication with packed dna polymerases
EP2548951B1 (en)	2006-03-23	2016-05-04	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007146106A2 (en) *	2006-06-05	2007-12-21	Cryo- Cell International, Inc.	Procurement, isolation and cryopreservation of maternal placental cells
CN101595212B (zh)	2006-10-12	2014-04-30	伊西康公司	肾源细胞及在组织修复和再生中的使用方法
CN101611139B (zh)	2006-11-13	2012-07-04	伊西康公司	利用微载体的产后来源的细胞的体外扩增
NZ612888A (en)	2007-02-12	2015-02-27	Anthrogenesis Corp	Treatment of inflammatory diseases using placental stem cells
US20080305148A1 (en)	2007-03-19	2008-12-11	National Yang Ming University	Treatment of spinal injuries using human umbilical mesenchymal stem cells
ES2525718T3 (es)	2007-10-05	2014-12-29	DePuy Synthes Products, LLC	Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano
US20090123620A1 (en) *	2007-11-14	2009-05-14	Hiti Thomas R	Automated Application of an Antimycotic Composition to Sliced Foodstuffs and an Antimycotic Application Apparatus
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
WO2009086215A2 (en)	2007-12-21	2009-07-09	Wyeth	Pathway analysis of cell culture phenotypes and uses thereof
UA99167C2 (ru)	2007-12-27	2012-07-25	Этикон, Инкорпорейтед	Лечение дегенерации межреберных дисков с использованием клеток, полученных из ткани пуповины человека
TWI387135B (zh) *	2008-03-28	2013-02-21	財團法人工業技術研究院	發光裝置及其製造方法
JP5518893B2 (ja)	2008-12-19	2014-06-11	アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー	肺ならびに肺の疾患および障害の治療
EP2379087B1 (en)	2008-12-19	2014-08-20	DePuy Synthes Products, LLC	Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
CN102458425A (zh)	2008-12-19	2012-05-16	伊西康公司	损伤后神经组织的再生和修复
EP2411504B1 (en)	2009-03-26	2017-05-10	DePuy Synthes Products, Inc.	Human umbilical cord tissue cells as therapy for alzheimer's disease
EP2666199B1 (en) *	2011-01-19	2017-06-21	E. I. du Pont de Nemours and Company	Lithium battery separator with shutdown function

2004
- 2004-06-25 EP EP10183053.7A patent/EP2399990B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517788A patent/JP4948166B2/ja not_active Expired - Fee Related
- 2004-06-25 JP JP2006517757A patent/JP4950659B2/ja not_active Expired - Fee Related
- 2004-06-25 PL PL04777287T patent/PL1641918T3/pl unknown
- 2004-06-25 ES ES04777234.8T patent/ES2600555T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252566A patent/AU2004252566B2/en not_active Ceased
- 2004-06-25 EP EP10184796.0A patent/EP2336298B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04777234T patent/PL1641915T3/pl unknown
- 2004-06-25 JP JP2006517786A patent/JP4948164B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES04777235.5T patent/ES2568463T3/es not_active Expired - Lifetime
- 2004-06-25 CA CA2530732A patent/CA2530732C/en not_active Expired - Fee Related
- 2004-06-25 PL PL04809466T patent/PL1649013T3/pl unknown
- 2004-06-25 PL PL04777235T patent/PL1641916T3/pl unknown
- 2004-06-25 EP EP04777286.8A patent/EP1641917B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04777286.8T patent/PL1641917T3/pl unknown
- 2004-06-25 PL PL10184796T patent/PL2336298T3/pl unknown
- 2004-06-25 US US10/877,009 patent/US7560276B2/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517787A patent/JP4948165B2/ja not_active Expired - Fee Related
- 2004-06-25 PL PL04777231T patent/PL1641914T3/pl unknown
- 2004-06-25 EP EP04777287.6A patent/EP1641918B1/en not_active Expired - Lifetime
- 2004-06-25 EP EP20100184137 patent/EP2338980B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517760A patent/JP4950661B2/ja not_active Expired - Fee Related
- 2004-06-25 ES ES10184796.0T patent/ES2569780T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004252568A patent/AU2004252568B2/en not_active Expired - Fee Related
- 2004-06-25 US US10/877,445 patent/US8703121B2/en active Active
- 2004-06-25 CA CA2530416A patent/CA2530416C/en not_active Expired - Fee Related
- 2004-06-25 WO PCT/US2004/020822 patent/WO2005001077A2/en not_active Ceased
- 2004-06-25 PL PL10184221T patent/PL2338981T3/pl unknown
- 2004-06-25 ES ES04756395.2T patent/ES2564044T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10184593.1T patent/ES2542070T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020823 patent/WO2005001078A2/en not_active Ceased
- 2004-06-25 WO PCT/US2004/020958 patent/WO2005038012A2/en not_active Ceased
- 2004-06-25 EP EP04777235.5A patent/EP1641916B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530412A patent/CA2530412C/en not_active Expired - Fee Related
- 2004-06-25 ES ES04809466.8T patent/ES2565582T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/877,269 patent/US7524489B2/en not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020931 patent/WO2005003334A2/en not_active Ceased
- 2004-06-25 EP EP04777234.8A patent/EP1641915B1/en not_active Expired - Lifetime
- 2004-06-25 CA CA2530533A patent/CA2530533C/en not_active Expired - Fee Related
- 2004-06-25 ES ES04777231.4T patent/ES2597837T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10184221.9T patent/ES2541604T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04777231.4A patent/EP1641914B1/en not_active Expired - Lifetime
- 2004-06-25 US US10/877,446 patent/US9579351B2/en not_active Expired - Fee Related
- 2004-06-25 CA CA2530421A patent/CA2530421C/en not_active Expired - Fee Related
- 2004-06-25 AU AU2004252570A patent/AU2004252570C1/en not_active Ceased
- 2004-06-25 PL PL10184306T patent/PL2338982T3/pl unknown
- 2004-06-25 ES ES10183053.7T patent/ES2550267T3/es not_active Expired - Lifetime
- 2004-06-25 PL PL10183911T patent/PL2341131T3/pl unknown
- 2004-06-25 PL PL10184137T patent/PL2338980T3/pl unknown
- 2004-06-25 WO PCT/US2004/020956 patent/WO2005001079A2/en not_active Ceased
- 2004-06-25 CA CA2530255A patent/CA2530255C/en not_active Expired - Fee Related
- 2004-06-25 EP EP10183911.6A patent/EP2341131B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL04756395T patent/PL1641913T3/pl unknown
- 2004-06-25 EP EP04756395.2A patent/EP1641913B1/en not_active Expired - Lifetime
- 2004-06-25 ES ES10184306.8T patent/ES2554343T3/es not_active Expired - Lifetime
- 2004-06-25 US US10/876,998 patent/US11191789B2/en not_active Expired - Fee Related
- 2004-06-25 ES ES10184137.7T patent/ES2542069T3/es not_active Expired - Lifetime
- 2004-06-25 AU AU2004254616A patent/AU2004254616C1/en not_active Ceased
- 2004-06-25 JP JP2006517783A patent/JP5148873B2/ja not_active Expired - Fee Related
- 2004-06-25 EP EP20100184221 patent/EP2338981B1/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004252571A patent/AU2004252571C1/en not_active Ceased
- 2004-06-25 CA CA2530422A patent/CA2530422C/en not_active Expired - Fee Related
- 2004-06-25 US US10/877,012 patent/US7510873B2/en not_active Expired - Lifetime
- 2004-06-25 EP EP10184593.1A patent/EP2322599B1/en not_active Expired - Lifetime
- 2004-06-25 PL PL10183053T patent/PL2399990T3/pl unknown
- 2004-06-25 EP EP10184306.8A patent/EP2338982B1/en not_active Expired - Lifetime
- 2004-06-25 AU AU2004252567A patent/AU2004252567B2/en not_active Ceased
- 2004-06-25 AU AU2004281371A patent/AU2004281371C1/en not_active Ceased
- 2004-06-25 US US10/877,541 patent/US7413734B2/en not_active Expired - Lifetime
- 2004-06-25 PL PL10184593T patent/PL2322599T3/pl unknown
- 2004-06-25 ES ES04777287.6T patent/ES2564045T3/es not_active Expired - Lifetime
- 2004-06-25 ES ES10183911.6T patent/ES2552226T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020957 patent/WO2005001080A2/en not_active Ceased
- 2004-06-25 ES ES04777286.8T patent/ES2582342T3/es not_active Expired - Lifetime
- 2004-06-25 WO PCT/US2004/020816 patent/WO2005001076A2/en not_active Ceased
- 2004-06-25 EP EP04809466.8A patent/EP1649013B1/en not_active Expired - Lifetime
- 2004-06-25 JP JP2006517759A patent/JP4950660B2/ja not_active Expired - Fee Related
2005
- 2005-12-22 US US11/316,104 patent/US9504719B2/en not_active Expired - Fee Related
- 2005-12-22 US US11/315,969 patent/US11179422B2/en not_active Expired - Fee Related
- 2005-12-23 US US11/317,574 patent/US20060234376A1/en not_active Abandoned
- 2005-12-29 US US11/321,863 patent/US20060153817A1/en not_active Abandoned
- 2005-12-29 US US11/322,003 patent/US20060154367A1/en not_active Abandoned
- 2005-12-29 US US11/321,864 patent/US20060153818A1/en not_active Abandoned
- 2005-12-30 US US11/322,372 patent/US20060188983A1/en not_active Abandoned
2006
- 2006-07-06 US US11/481,456 patent/US8318483B2/en not_active Expired - Fee Related
- 2006-07-06 US US11/481,480 patent/US20070009494A1/en not_active Abandoned
- 2006-07-06 US US11/481,481 patent/US20070014771A1/en not_active Abandoned
2009
- 2009-02-19 US US12/389,305 patent/US9498501B2/en not_active Expired - Fee Related
- 2009-04-24 US US12/429,849 patent/US8277796B2/en not_active Expired - Fee Related
2012
- 2012-09-06 US US13/605,716 patent/US8658152B2/en not_active Expired - Fee Related
2013
- 2013-09-05 US US14/018,842 patent/US9717763B2/en not_active Expired - Fee Related
2016
- 2016-11-28 US US15/362,453 patent/US10039793B2/en not_active Expired - Lifetime
2017
- 2017-02-27 US US15/443,733 patent/US10383898B2/en not_active Expired - Fee Related
- 2017-02-27 US US15/443,718 patent/US10195233B2/en not_active Expired - Lifetime
- 2017-02-27 US US15/443,602 patent/US10220059B2/en not_active Expired - Lifetime
- 2017-07-27 US US15/661,878 patent/US10500234B2/en not_active Expired - Fee Related
2018
- 2018-08-06 US US16/056,146 patent/US10758576B2/en not_active Expired - Fee Related
2019
- 2019-03-04 US US16/291,784 patent/US11000554B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL2399990T3 (pl)	2015-12-31
AU2004252566A1 (en)	2005-01-06
ES2569780T3 (es)	2016-05-12
PL2338982T3 (pl)	2016-01-29
JP4948165B2 (ja)	2012-06-06
EP1641917A2 (en)	2006-04-05
US20070014771A1 (en)	2007-01-18
US20170326183A1 (en)	2017-11-16
ES2565582T3 (es)	2016-04-05
EP1649013B1 (en)	2016-01-20
WO2005001079A3 (en)	2005-04-28
EP1641914B1 (en)	2016-07-20
US20170166863A1 (en)	2017-06-15
US20170239299A1 (en)	2017-08-24
CA2530412A1 (en)	2005-04-28
JP5148873B2 (ja)	2013-02-20
US10039793B2 (en)	2018-08-07
US8658152B2 (en)	2014-02-25
WO2005001078A2 (en)	2005-01-06
EP2399990A1 (en)	2011-12-28
US20130022585A1 (en)	2013-01-24
JP2007521793A (ja)	2007-08-09
ES2552226T3 (es)	2015-11-26
ES2564045T3 (es)	2016-03-17
AU2004252567B2 (en)	2011-10-06
EP1641916B1 (en)	2016-02-17
EP1641915A2 (en)	2006-04-05
EP1649013A2 (en)	2006-04-26
AU2004252570B2 (en)	2011-09-15
US8277796B2 (en)	2012-10-02
US20050054098A1 (en)	2005-03-10
ES2541604T3 (es)	2015-07-22
US20100210013A1 (en)	2010-08-19
WO2005001078A3 (en)	2005-04-21
AU2004252570C1 (en)	2012-03-01
WO2005001076A3 (en)	2005-03-31
EP2338982B1 (en)	2015-08-26
US8318483B2 (en)	2012-11-27
ES2600555T3 (es)	2017-02-09
AU2004252570A1 (en)	2005-01-06
EP2338981B1 (en)	2015-04-22
AU2004252571C1 (en)	2012-03-01
PL1641917T3 (pl)	2016-11-30
CA2530412C (en)	2016-02-09
WO2005003334A2 (en)	2005-01-13
CA2530732A1 (en)	2005-01-06
AU2004281371B2 (en)	2012-05-10
US20170143770A1 (en)	2017-05-25
EP2338980A2 (en)	2011-06-29
EP1641918B1 (en)	2016-01-06
US20170166864A1 (en)	2017-06-15
EP2322599B1 (en)	2015-04-15
US20060153816A1 (en)	2006-07-13
US20070036767A1 (en)	2007-02-15
CA2530416A1 (en)	2005-01-06
US9717763B2 (en)	2017-08-01
EP2338981A2 (en)	2011-06-29
US11191789B2 (en)	2021-12-07
US7510873B2 (en)	2009-03-31
JP2007521008A (ja)	2007-08-02
EP2338982A2 (en)	2011-06-29
AU2004254616B2 (en)	2011-09-01
JP2007521009A (ja)	2007-08-02
CA2530533A1 (en)	2005-01-13
EP2336298A2 (en)	2011-06-22
EP2338980A3 (en)	2011-08-10
US20060234376A1 (en)	2006-10-19
JP2007528703A (ja)	2007-10-18
PL1641916T3 (pl)	2016-08-31
CA2530533C (en)	2015-02-10
JP2007528705A (ja)	2007-10-18
US10220059B2 (en)	2019-03-05
CA2530255C (en)	2015-12-08
WO2005003334A3 (en)	2005-04-07
CA2530421C (en)	2015-04-21
US20050019865A1 (en)	2005-01-27
ES2568463T3 (es)	2016-04-29
JP4948164B2 (ja)	2012-06-06
US9498501B2 (en)	2016-11-22
WO2005001077A3 (en)	2005-03-03
EP1641917B1 (en)	2016-04-27
CA2530255A1 (en)	2005-01-06
ES2582342T3 (es)	2016-09-12
JP4950660B2 (ja)	2012-06-13
EP1641915B1 (en)	2016-07-27
PL2341131T3 (pl)	2016-01-29
US7560276B2 (en)	2009-07-14
AU2004252571B2 (en)	2011-09-15
PL1641918T3 (pl)	2016-06-30
ES2597837T3 (es)	2017-01-23
WO2005001080A3 (en)	2005-03-24
ES2564044T3 (es)	2016-03-17
AU2004254616A1 (en)	2005-01-13
EP2399990B1 (en)	2015-07-22
US20070009494A1 (en)	2007-01-11
PL1641914T3 (pl)	2017-01-31
EP2338982A3 (en)	2011-08-03
EP1641913B1 (en)	2016-01-06
ES2542069T3 (es)	2015-07-30
AU2004252568A1 (en)	2005-01-06
WO2005001077A2 (en)	2005-01-06
AU2004281371A1 (en)	2005-04-28
PL2322599T3 (pl)	2015-10-30
PL1649013T3 (pl)	2016-07-29
CA2530422C (en)	2016-01-05
US20060153818A1 (en)	2006-07-13
US20100260843A1 (en)	2010-10-14
EP2336298B1 (en)	2016-02-17
PL2336298T3 (pl)	2016-08-31
US7524489B2 (en)	2009-04-28
EP2338980B1 (en)	2015-04-22
EP2341131B1 (en)	2015-08-05
US20050058631A1 (en)	2005-03-17
PL2338981T3 (pl)	2016-01-29
US20060153817A1 (en)	2006-07-13
EP2336298A3 (en)	2011-08-03
AU2004252568B2 (en)	2011-06-30
EP1641918A2 (en)	2006-04-05
ES2550267T3 (es)	2015-11-05
CA2530421A1 (en)	2005-01-06
US20060154367A1 (en)	2006-07-13
US7413734B2 (en)	2008-08-19
AU2004252571A1 (en)	2005-01-06
US10383898B2 (en)	2019-08-20
US8703121B2 (en)	2014-04-22
CA2530422A1 (en)	2005-01-06
EP1641913A2 (en)	2006-04-05
US10195233B2 (en)	2019-02-05
US20180338999A1 (en)	2018-11-29
JP2007528706A (ja)	2007-10-18
WO2005001080A2 (en)	2005-01-06
US10758576B2 (en)	2020-09-01
US20050037491A1 (en)	2005-02-17
ES2542070T3 (es)	2015-07-30
EP2341131A2 (en)	2011-07-06
US20060154366A1 (en)	2006-07-13
US20050058630A1 (en)	2005-03-17
AU2004252567A1 (en)	2005-01-06
JP4950661B2 (ja)	2012-06-13
EP1641914A2 (en)	2006-04-05
US20050032209A1 (en)	2005-02-10
ES2554343T3 (es)	2015-12-18
US11000554B2 (en)	2021-05-11
EP1641916A2 (en)	2006-04-05
US9579351B2 (en)	2017-02-28
PL2338980T3 (pl)	2016-04-29
US20050058629A1 (en)	2005-03-17
US20060188983A1 (en)	2006-08-24
WO2005001076A2 (en)	2005-01-06
US11179422B2 (en)	2021-11-23
US10500234B2 (en)	2019-12-10
US20140045263A1 (en)	2014-02-13
AU2004254616C1 (en)	2012-03-01
EP2322599A2 (en)	2011-05-18
EP2341131A3 (en)	2011-08-03
US9504719B2 (en)	2016-11-29
CA2530416C (en)	2015-08-25
CA2530732C (en)	2015-03-31
WO2005038012A3 (en)	2005-09-15
AU2004281371C1 (en)	2012-10-11
WO2005038012A2 (en)	2005-04-28
US20190192577A1 (en)	2019-06-27
JP4950659B2 (ja)	2012-06-13
JP4948166B2 (ja)	2012-06-06
JP2007528702A (ja)	2007-10-18
EP2322599A3 (en)	2011-07-27
PL1641915T3 (pl)	2017-01-31
AU2004252566B2 (en)	2011-09-15
WO2005001079A2 (en)	2005-01-06
EP2338981A3 (en)	2011-08-03

Publication	Publication Date	Title
PL1641913T3 (pl)	2016-06-30	Komórki poporodowe pochodzące z tkanek pępowinowych i sposoby ich wytwarzania i zastosowania
PL1831356T3 (pl)	2017-07-31	Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania
IL213284A0 (en)	2011-07-31	Dermal micro organs, methods and apparatuses for producing and using the same
EP1599122A4 (en)	2009-04-29	SYSTEM AND METHOD FOR NON-FEVER TISSUE CHARACTERIZATION
AU2003902503A0 (en)	2003-06-05	Medical Apparatus, Use and Methods
EP1578719A4 (en)	2006-07-05	P-HYDROXY-MILNACIPRAN STEREOISOMERS AND METHODS OF USING THE SAME
AU2003243534A1 (en)	2003-12-22	Methods and devices for electrosurgical electrolysis
PL375691A1 (pl)	2005-12-12	Imidazolopirydyny i sposoby ich wytwarzania i stosowania
EP1695653A4 (en)	2009-07-08	ENDOSCOPY SYSTEM AND ENDOSCOPE
EP1596656A4 (en)	2006-10-18	PYRAZOLES AND METHODS OF MAKING AND USING THEM
AU2003225705A1 (en)	2004-09-30	Cytidine analogs and methods of use
AU2003301066A1 (en)	2004-09-06	Al2o3-la2o3-y2o3-mgo ceramics, and methods of making the same
ZA200409492B (en)	2006-02-22	Compositions and methods for the diagnosis and treatment of tumor.
AU2003296379A1 (en)	2004-06-30	Methods and devices for cardiac surgery
WO2005003154A8 (en)	2005-06-16	Compositions and methods for the diagnosis and treatment of tumor
AU2003237792A1 (en)	2004-11-23	Compositions and methods for the diagnosis and treatment of tumor
PL1653982T3 (pl)	2019-05-31	Leczenie halitozy
GB0328621D0 (en)	2004-01-14	Heart rate monitor
IL175303A0 (en)	2006-09-05	Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
EP1689285A4 (en)	2008-01-02	HEART DISTRIBUTION DEVICES AND METHOD
IL175137A0 (en)	2006-09-05	Bace455, an alternative splice variant of the human beta-secretase
AU2003263962A8 (en)	2004-02-16	Tissue compositions and methods for producing same
WO2005052191A8 (en)	2005-09-01	Compositions and methods for the diagnosis and treatment of tumor
AU2003260187A8 (en)	2005-04-06	Methods of modulating bone growth, bone remodeling and adiposity
AU2003300607A8 (en)	2004-08-13	Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof